[go: up one dir, main page]

CN1760193A - Antifungal compound of alkyl substitutional triazole class - Google Patents

Antifungal compound of alkyl substitutional triazole class Download PDF

Info

Publication number
CN1760193A
CN1760193A CN 200510030746 CN200510030746A CN1760193A CN 1760193 A CN1760193 A CN 1760193A CN 200510030746 CN200510030746 CN 200510030746 CN 200510030746 A CN200510030746 A CN 200510030746A CN 1760193 A CN1760193 A CN 1760193A
Authority
CN
China
Prior art keywords
substituted
ring
methyl
ethyl
triazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200510030746
Other languages
Chinese (zh)
Inventor
刘超美
何秋琴
门秀峰
曹永兵
董玉环
赵荔华
姜远英
赵靖霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Second Military Medical University SMMU
Original Assignee
Second Military Medical University SMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Second Military Medical University SMMU filed Critical Second Military Medical University SMMU
Priority to CN 200510030746 priority Critical patent/CN1760193A/en
Publication of CN1760193A publication Critical patent/CN1760193A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)

Abstract

本发明涉及通式(I)的烷基取代的三氮唑类化合物,式中R为叔丁基,M为氢或甲基,Z为杂环或取代杂环;取代稠合杂环;取代砜基、亚砜基和胺基等;取代哌嗪、噻唑、氢化咪唑啉酮等;取代哌嗪苯氧基。取代基包括烷基、卤素、取代苯环、苄基、苯甲酰基、取代杂环、杂环甲基、杂环甲酰基、取代咪唑啉酮苯基和取代三唑酮苯基等,这些苯环和杂环上的取代基指1-6个碳原子的基团、卤素、吸电子基团或供电子基团。可在苯环和杂环上任何可能的位置,可是单取代或多取代。本发明还包括上述化合物的各种对映异构体、非对映异构体、氮氧化物和前体药物,及常见药用盐类。本发明的化合物具有很强的抗真菌活性,可用于抗真菌药物的制备。

Figure 200510030746

The present invention relates to alkyl-substituted triazole compounds of general formula (I), wherein R is tert-butyl, M is hydrogen or methyl, and Z is heterocycle or substituted heterocycle; substituted fused heterocycle; substituted Sulfone group, sulfoxide group and amino group, etc.; substituted piperazine, thiazole, hydrogenated imidazolinone, etc.; substituted piperazine phenoxy group. Substituents include alkyl, halogen, substituted benzene ring, benzyl, benzoyl, substituted heterocycle, heterocyclic methyl, heterocyclic formyl, substituted imidazolinone phenyl and substituted triazolone phenyl, etc., these benzene The substituents on rings and heterocycles refer to groups of 1-6 carbon atoms, halogens, electron-withdrawing groups or electron-donating groups. Any possible position on the benzene and heterocyclic rings, mono- or poly-substituted. The present invention also includes various enantiomers, diastereomers, nitrogen oxides and prodrugs of the above compounds, as well as common pharmaceutically acceptable salts. The compound of the invention has strong antifungal activity and can be used in the preparation of antifungal drugs.

Figure 200510030746

Description

The triazole antifungal compound that alkyl replaces
Technical field
The present invention relates to medical technical field, is a kind of novel alkyl triazole antifungal compound, has replaced 2,4 difluorobenzene base in the common azole antifungal compound molecule with alkyl: 1-(1H-1,2,4-triazol-1-yl)-2-alkyl-3-replacement-2-propyl alcohol.
Background technology
In recent years, along with antibiotic a large amount of uses, the increase of the chemicotherapy of tumour patient and organ transplantation patient number, the generally employing of conduit and intubate, being extensive use of of cortin and immunosuppressor, and especially acquired immune deficiency syndrome (AIDS) patient's increase rapidly of immune deficiency patient, cause fungi infestation particularly the deep fungal infection sickness rate sharply increase.Deep fungal infection has risen to the third-largest communicable disease clinically, and human beings'health in serious threat.Statistical information shows that 60% the direct cause of death is a deep fungal infection among the AIDS patient.Therefore, press for efficient, low toxicity, novel deep antifungal drug that selectivity is high clinically.
At present, the medicine that is used for the treatment of deep fungal infection still has only amphotericin B (Amphotericin B), fluconazole (Fluconazole) and itraconazole (Itraconazole) to wait a few medicine.Amphotericin B is still the golden standard of antifungal drug, but side effect is serious, and as generating heat, shivering, especially serious renal toxicity has limited its clinical application.At present, fluconazole and itraconazole are most widely used, but the resistance problem that is on the rise and limited its clinical application to some bacterial strain curative effect is relatively poor.Find in the recent report of survey, exist the chemical sproof Candida albicans of fluconazole in 33% the AIDS patient oral cavity.
The mechanism of action of nitrogen azole drug is the ferrous atom complexing mutually on N atom and fungal cell's cytochrome p 450 14 α-sterol demethyl enzyme (CYP51) the protoheme porphyryl on the triazole ring, thereby interrupt the 14 α demethylations reaction of substrate lanosterol, make the ergosterol biosynthesis block, lanosterol is accumulated, cell flowability, membrane permeability and enzyme activity change, 26S Proteasome Structure and Function disappears, and finally causes fungi death.Since the nineties in last century, synthesized ten hundreds of triazole class compounds both at home and abroad, vivocon azoles (Voriconazole) has been got permission listing in 2002; Pressgang health azoles (Ravuconazole), general Saperconazole (Posaconazole) and TAK-187 etc. are carrying out clinical study.The structural difference of these compounds and fluconazole and itraconazole is all less, is easy to produce cross resistance, and all contains the 2,4 difluorobenzene base.Early stage structure activity study shows that phenyl is essential by anti-mycotic activity, and preferably 2,4-dichloro or 2, the phenyl that the 4-difluoro replaces, but the phenyl that halogen replaces in vivo during metabolism toxicity bigger.Compare with fluconazole, vivocon azoles and pressgang health azoles etc. are at present at clinical use or the s-generation triadimenol compounds has a broad antifungal spectrum that grinding, anti-microbial activity to the Eurotium fungi obviously strengthens, equally matched with itraconazole, and it is effective to the bacterial strain of anti-the fluconazole, its constitutional features is to have increased a methyl at 3, has increased a chiral carbon atom, and synthetic difficulty significantly increases.
Summary of the invention
For solving the deficiencies in the prior art, more provided by the invention with tertiary butyl replacement 2, the compound of 4-difluorophenyl, from external bacteriostatic activity, activity to deep fungal, superficial fungi, aspergillus tubigensis and the bacterial strain of anti-the fluconazole all can be compared with itraconazole, some in addition be better than itraconazole, illustrate that three methyl of the tertiary butyl have an effect of having played 3 methyl in vivocon azoles and the pressgang health azoles equimolecular, and do not increase the quantity of chiral carbon atom.The invention provides with the tertiary butyl and replace 2, the novel triazole antifungal agents of 4-difluorophenyl and efficient, low toxicity, wide spectrum, and common medicinal salts such as hydrochloride, phosphoric acid salt, methane sulfonates, oxalate, maleate, fumarate, tartrate, lactic acid salt and succinate.
The general structure of The compounds of this invention is as follows:
Figure A20051003074600101
Wherein R representative:
Figure A20051003074600102
Here a, b, c are respectively the group that contains 1-6 carbon atom, as methyl, ethyl, propyl group, butyl, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl etc.; Can be identical, also can be different.
In the Compound I: M represents hydrogen or has 1~4 carbon atom group, as methyl, ethyl, trifluoromethyl etc., preferable methyl.
The Z representative:
(1) heterocycle or substituted heterocycle:
The heterocycle here is meant five Yuans or six element heterocycles, be selected from furans, thiophene, pyrazoles, imidazoles, triazole, tetrazole, oxazole, thiazole, isoxazole, pyridine, pyrimidine, pyrazolone, hydrogenation pyrazolone, 2-imidazolone, 4,5-glyoxalidine quinoline ketone, 1,2,4-triazole-3-ketone, piperazine, morpholine and piperidines.Substituting group can be positioned at each position of heterocyclic on the heterocycle, can be single replacement, also can be polysubstituted.Substituting group refers to:
1) contains the group of 1-6 carbon atom, as methyl, ethyl, trifluoromethyl, methylol, methoxyl methyl, ethoxymethyl, sec.-propyl and the tertiary butyl;
2) halogen is as F, Cl, Br, I;
3) electron-withdrawing group or electron-donating group, as methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N-methyl carbamyl, N-ethyl carbamyl, N, N-dimethylamino formyl radical, N, N-diethyl amino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group;
4) para-orientation styryl, the substituting group on the phenyl ring are F, Cl, Br, I; Methylsulfonyl, first sulfoxide group, methyl, ethyl, trifluoromethyl, trifluoromethoxy, tetrafluoro oxyethyl group, tetrafluoro propoxy-, methoxyl methyl, sec.-propyl and the tertiary butyl.
(2) substituted fused heterocycle:
The annelated heterocycles here is meant that phenyl ring and five Yuans or six element heterocycles condense, and five Yuans or six element heterocycles are selected from furans, thiophene, pyrazoles, imidazoles, triazole, oxazole, thiazole, isoxazole, pyrans, pyridine and pyrimidine.Substituting group can be positioned on the phenyl ring and heterocycle on, can be single replacement, also can be polysubstituted.Substituting group refers to:
1) contains the group of 1-6 carbon atom, as methyl, ethyl, trifluoromethyl, methylol, methoxyl methyl, ethoxymethyl, sec.-propyl and the tertiary butyl;
2) halogen is as F, Cl, Br, I;
3) electron-withdrawing group or electron-donating group, as methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N-methyl carbamyl, N-ethyl carbamyl, N, N-dimethylamino formyl radical, N, N-diethyl amino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group;
4) para-orientation styryl, the substituting group on the phenyl ring are F, Cl, Br, I; Methylsulfonyl, first sulfoxide group, methyl, ethyl, trifluoromethyl, trifluoromethoxy, tetrafluoro oxyethyl group, tetrafluoro propoxy-, methoxyl methyl, sec.-propyl and the tertiary butyl.
(3)
X-B
X is O, S, NH, SO, SO 2Deng; B is:
1) contains the group of 1-6 carbon atom, as methyl, ethyl, trifluoromethyl, methylol, methoxyl methyl, sec.-propyl, cyclopentyl and cyclohexyl etc.;
2) substituted-phenyl, the substituting group here are 1-3, can be the same or different, as F, Cl, Br, I; Methyl, ethyl, trifluoromethyl, sec.-propyl, the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N-methyl carbamyl, N-ethyl carbamyl, N, N-dimethylamino formyl radical, N, N-diethyl amino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.;
3) substituted heterocycle, the heterocycle here is meant five Yuans or six element heterocycles, be selected from furans, thiophene, pyrazoles, imidazoles, triazole, oxazole, thiazole, isoxazole, pyrans, pyridine, pyrimidine, pyrazolone, hydrogenation pyrazolone, 2-imidazolone, 4,5-glyoxalidine quinoline ketone, 1,2,4-triazole-3-ketone, piperazine, morpholine and piperidines.Substituting group can be positioned at each position of heterocyclic on the heterocycle, can be single replacement, also can be polysubstituted.As F, Cl, Br, I; Methyl, ethyl, trifluoromethyl, sec.-propyl, the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N-methyl carbamyl, N-ethyl carbamyl, N, N-dimethylamino formyl radical, N, N-diethyl amino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.;
4) substituted aroma cyclohexyl methyl, five Yuans or six Yuans fragrance (mixing) ring that the fragrant fourth finger here is common are selected from phenyl ring, furans, thiophene, pyrazoles, imidazoles, triazole, tetrazole, oxazole, thiazole, isoxazole, pyrans, pyridine and pyrimidine.Fragrance (mixing) substitution in ring base can be positioned at each position, can be single replacement, also can be polysubstituted.As F, Cl, Br, I; Methyl, ethyl, trifluoromethyl, sec.-propyl, the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N-methyl carbamyl, N-ethyl carbamyl, N; N-dimethylamino formyl radical, N, N-diethyl amino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.
(4)
X 1-C
X 1Be various heterocycles, as furans, thiophene, pyrazoles, imidazoles, triazole, tetrazole, oxazole, thiazole, isoxazole, pyrans, pyridine, pyrimidine, piperazine, morpholine, piperidines, pyrazolone, hydrogenation pyrazolone, 2-imidazolone, 4,5-glyoxalidine quinoline ketone, 1,2,4-triazole-3-ketone etc.;
1) C is C 1The time, C 1Be
A. substituted-phenyl, the substituting group here can be 1-3, can be the same or different, as F, Cl, Br, I; Methyl, ethyl, trifluoromethyl, sec.-propyl, the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N-methyl carbamyl, N-ethyl carbamyl, N, N-dimethylamino formyl radical, N, N-diethyl amino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.; Substituting group can be positioned at each position of phenyl ring;
B. substituted heterocycle, the heterocycle here is meant five Yuans or six element heterocycles, is selected from furans, thiophene, pyrazoles, imidazoles, triazole, oxazole, thiazole, isoxazole, pyrans, pyridine, pyrimidine, morpholine and piperidines.Substituting group can be positioned at each position of heterocyclic on the heterocycle, can be single replacement, also can be polysubstituted.As F, Cl, Br, I methyl, ethyl, trifluoromethyl, sec.-propyl, the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N-methyl carbamyl, N-ethyl carbamyl, N, N-dimethylamino formyl radical, N, N-diethyl amino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.;
C. substituted aroma cyclohexyl methyl, five Yuans or six Yuans fragrance (mixing) ring that the fragrant fourth finger here is common are selected from phenyl ring, furans, thiophene, pyrazoles, imidazoles, triazole, tetrazole, oxazole, thiazole, isoxazole, pyrans, pyridine and pyrimidine.Fragrance (mixing) substitution in ring base can be positioned at each position, can be single replacement, also can be polysubstituted.As F, Cl, Br, I; Methyl, ethyl, trifluoromethyl, sec.-propyl, the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N-methyl carbamyl, N-ethyl carbamyl, N, N-dimethylamino formyl radical, N, N-diethyl amino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.;
D. replace ethanoyl, the substituting group here refers to substituted benzene ring and heterocycle again, and the heterocycle here is meant five Yuans or six element heterocycles, is selected from furans, thiophene, pyrazoles, imidazoles, triazole, oxazole, thiazole, isoxazole, pyrans, pyridine, pyrimidine, morpholine and piperidines.Substituting group is 1-3 on phenyl ring and the heterocycle, can be single replacement, also can be polysubstituted.As F, Cl, Br, I; Methyl, ethyl, trifluoromethyl, sec.-propyl, the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N-methyl carbamyl, N, N-dimethylamino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.;
E. substituted formyl methyl, the substituting group here refers to substituted aniline and heterocycle amido again, the heterocycle here is meant five Yuans or six element heterocycles, is selected from furans, thiophene, pyrazoles, imidazoles, triazole, oxazole, thiazole, isoxazole, pyrans, pyridine, pyrimidine, morpholine and piperidines.Substituting group is 1-3 on phenyl ring and the heterocycle, can be single replacement, also can be polysubstituted.As F, Cl, Br, I; Methyl, ethyl, trifluoromethyl, sec.-propyl, the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N, N-dimethylamino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.;
2) C is C 2The time, C 2Be
Figure A20051003074600131
X 2Be S, O, NH.
E is: the substituted aroma cyclohexyl methyl, five Yuans or six Yuans fragrance (mixing) ring that the fragrant fourth finger here is common are selected from phenyl ring, furans, thiophene, pyrazoles, imidazoles, triazole, oxazole, thiazole, isoxazole, pyrans, pyridine and pyrimidine.Fragrance (mixing) substitution in ring base can be positioned at each position, can be single replacement, also can be polysubstituted.As F, Cl, Br, I; Methyl, ethyl, trifluoromethyl, sec.-propyl, the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N-methyl carbamyl, N-ethyl carbamyl, N, N-dimethylamino formyl radical, N, N-diethyl amino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.;
X 2E can also be a substituted aroma ring formyl radical during for NH, and the fragrant fourth finger here common five Yuans or six Yuans fragrance (mixing) ring are selected from phenyl ring, furans, thiophene, pyrazoles, imidazoles, triazole, oxazole, thiazole, isoxazole, pyrans, pyridine and pyrimidine.Fragrance (mixing) substitution in ring base can be positioned at each position, can be single replacement, also can be polysubstituted.As F, Cl, Br, I; Methyl, ethyl, trifluoromethyl, sec.-propyl, the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N-methyl carbamyl, N-ethyl carbamyl, N, N-dimethylamino formyl radical, N, N-diethyl amino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.;
3) C is C 3The time, C 3Be
Figure A20051003074600141
Q is CH or N; G is:
A. the group that contains 1-6 carbon atom is as methyl, ethyl, trifluoromethyl, sec.-propyl, isobutyl-and the tertiary butyl, cyclopentyl and cyclohexyl etc.;
B. substituted aroma ring, five Yuans or six Yuans fragrance (mixing) ring that the fragrant fourth finger here is common are selected from phenyl ring, furans, thiophene, pyrazoles, imidazoles, triazole, oxazole, thiazole, isoxazole, pyrans, pyridine and pyrimidine.Fragrance (mixing) substitution in ring base can be positioned at each position, can be single replacement, also can be polysubstituted.As F, Cl, Br, I; Methyl, ethyl, trifluoromethyl, sec.-propyl and the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N-methyl carbamyl, N-ethyl carbamyl, N, N-dimethylamino formyl radical, N, N-diethyl amino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.;
C. substituted aroma cyclohexyl methyl, five Yuans or six Yuans fragrance (mixing) ring that the fragrant fourth finger here is common are selected from phenyl ring, furans, thiophene, pyrazoles, imidazoles, triazole, oxazole, thiazole, isoxazole, pyrans, pyridine and pyrimidine.Fragrance (mixing) substitution in ring base can be positioned at each position, can be single replacement, also can be polysubstituted.As F, Cl, Br, I; Methyl, ethyl, trifluoromethyl, sec.-propyl, the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N-methyl carbamyl, N-ethyl carbamyl, N, N-dimethylamino formyl radical, N, N-diethyl amino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.;
4) C is C 4The time, C 4Be
With
R 2For: 1-3 F, Cl, Br can be the same or different.A and A 1Can be O, S, N or NH.R 3For:
1) contains the group of 1-6 carbon atom, as methyl, ethyl, propyl group, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl etc.;
2) substituted aroma ring, five Yuans or six Yuans fragrance (mixing) ring that the fragrant fourth finger here is common are selected from phenyl ring, furans, thiophene, pyrazoles, imidazoles, triazole, oxazole, thiazole, isoxazole, pyrans, pyridine and pyrimidine.Fragrance (mixing) substitution in ring base can be positioned at each position, can be single replacement, also can be polysubstituted.As F, Cl, Br, I; Methyl, ethyl, trifluoromethyl, sec.-propyl, the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N-methyl carbamyl, N-ethyl carbamyl, N, N-dimethylamino formyl radical, N, N-diethyl amino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.;
3) substituted aroma cyclohexyl methyl, five Yuans or six Yuans fragrance (mixing) ring that the fragrant fourth finger here is common are selected from phenyl ring, furans, thiophene, pyrazoles, imidazoles, triazole, oxazole, thiazole, isoxazole, pyrans, pyridine and pyrimidine.Fragrance (mixing) substitution in ring base can be positioned at each position, can be single replacement, also can be polysubstituted.As F, Cl, Br, I; Methyl, ethyl, trifluoromethyl, sec.-propyl, the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N-methyl carbamyl, N-ethyl carbamyl, N; N-dimethylamino formyl radical, N, N-diethyl amino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.
(5)
R 1For:
1) contains the group of 1-6 carbon atom, as methyl, ethyl, ethanoyl, sec.-propyl, propionyl and butyryl radicals etc.;
2) substituted aroma ring, five Yuans or six Yuans fragrance (mixing) ring that the fragrant fourth finger here is common are selected from phenyl ring, furans, thiophene, pyrazoles, imidazoles, triazole, oxazole, thiazole, isoxazole, pyrans, pyridine and pyrimidine.Fragrance (mixing) substitution in ring base can be positioned at each position, can be single replacement, also can be polysubstituted.As F, Cl, Br, I; Methyl, ethyl, trifluoromethyl, sec.-propyl, the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, formamido group, carbamyl, N-methyl carbamyl, N-ethyl carbamyl, N, N-dimethylamino formyl radical, N, N-diethyl amino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.;
3) substituted aroma cyclohexyl methyl, five Yuans or six Yuans fragrance (mixing) ring that the fragrant fourth finger here is common are selected from phenyl ring, furans, thiophene, pyrazoles, imidazoles, triazole, oxazole, thiazole, isoxazole, pyrans, pyridine and pyrimidine.Fragrance (mixing) substitution in ring base can be positioned at each position, can be single replacement, also can be polysubstituted.As F, Cl, Br, I; Methyl, ethyl, trifluoromethyl, sec.-propyl, the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, carbamyl, N-methyl carbamyl, N-ethyl carbamyl, N, N-dimethylamino formyl radical, N, N-diethyl amino formyl radical, methoxy acyl group, ethoxy acyl group, amino, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.;
4) substituted aroma ring formyl radical; five Yuans or six Yuans fragrance (mixing) ring that the fragrant fourth finger here is common; be selected from phenyl ring, furans, thiophene, pyrazoles, imidazoles, triazole, oxazole, thiazole, isoxazole, pyrans, pyridine and pyrimidine; fragrance (mixing) substitution in ring base can be positioned at each position; can be single replacement, also can be polysubstituted.As F, Cl, Br, I; Methyl, ethyl, trifluoromethyl, sec.-propyl, the tertiary butyl etc.; Methylsulfonyl, first sulfoxide group, nitro, cyano group, kharophen, hydroxyl, methoxyl group, oxyethyl group etc.;
5)
Figure A20051003074600161
Q is CH or N; Y is: contain the group of 1-6 carbon atom, as methyl, ethyl, trifluoromethyl, sec.-propyl, isobutyl-and isopentyl etc.
The compounds of this invention also comprises various enantiomers, diastereomer, oxynitride and the prodrug of above-claimed cpd, and common medicinal salts such as hydrochloride, phosphoric acid salt, methane sulfonates, acetate, oxalate, maleate, fumarate, grape hydrochlorate, tartrate, lactic acid salt and succinate.
The building-up reactions flow process of The compounds of this invention is as follows:
1. the preparation of intermediate (III):
Figure A20051003074600171
1,2, a 4-triazole and a chloropinacolone (V) are at K 2CO 3Effect generates alpha-triazolyl pinacolone (VI) (reference US4486218) down; With the nucleophilic additions of sulphur Yi Lide (ylid) reagent trimethylammonium oxygen sulphur iodide at 60 ℃ of generation carbonyls, form epoxide, it can with the methanesulfonic salify, get intermediate 1-(the 2-tertiary butyl-2, the 3-epoxypropyl)-1H-1,2,4-triazole methane sulfonates (III) (reference US4499281).
2. intermediate (III) is at NaH, NaOH or K 2CO 3Effect in alkali just obtains target compound (I) with the nucleophilicity reagent react that contains oxygen, sulphur, nitrogen down; Target compound (I) just can make its salt with corresponding acid-respons.As:
Ring-opening reaction takes place with single substituted piperazine like compound and promptly generates the triadimenol compounds (I) that piperazine replaces in intermediate epoxide (III) under alkaline condition.(I) with the acid-respons of equivalent 1~2 hour, after reaction finished, concentration of reaction solution must precipitate, and filtered the precipitation that produces and was salt.
Embodiment:
Below the test of part example and bacteriostatic test are further illustrated alkyl triazole antifungal compound of the present invention and beneficial effect thereof by experiment.
Experimental section
Fusing point Yamato model MP-21 type melting point detector, capillary tube technique is measured, and temperature is not calibrated.Ultimate analysis is measured with MOD-1106 type elemental analyser, requires C, H, and the measured value and the calculated value of three kinds of ultimate analyses of N differ less than 0.3%.Infrared spectra Hitachi 270-50 type determination of infrared spectroscopy, the KBr pressed disc method.Nuclear magnetic resonance spectrum is with Bruke Spectrospin AC-P300 type nmr determination, with DMSO-d 6Or CDCl 3Be solvent, TMS is interior mark.It is synthetic that reference substance fluconazole and itraconazole are pharmaceutical college of The 2nd Army Medical College.Agents useful for same is commercial analytical pure.
Embodiment 1
Synthesizing of 1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-(2-pyridine sulfydryl)-2-propyl alcohol
Get 1.78g (16mmol) 2-mercaptopyridine, 4.15g (15mmol) 1-(1H-1,2, the 4-triazol-1-yl)-the 2-tertiary butyl-2,3-propylene oxide methane sulfonates and 5.52g (40mmol) salt of wormwood is put into the 100ml three-necked bottle, add a little Tetrabutyl amonium bromide and 55ml DMF again, in 75 ℃ of stirring reaction 8h, filter, filtrate is transferred pH=2 with hydrochloric acid, ethyl acetate washing (30ml * 3), water is transferred pH=10 with 10% sodium hydroxide, filter out solid, use the dehydrated alcohol recrystallization, get pale yellow powder 1.4g, yield 31.96%, mp:68-70 ℃.
1H-NMR (DMSO-d 6) δ, ppm:8.44 (1H, s, triazole C 3-H), 7.91 (1H, s, triazole C 5-H), 8.32 (1H, d, pyridine-C 6-H), 7.62 (1H, m, pyridine-C 4-H), 7.28 (1H, d, pyridine-C 3-H), 7.12 (1H, m, pyridine-C 5-H), 5.50 (1H, s, OH), 4.39 (1H, s ,-SCH 2-), 3.28-3.54 (2H, AB system, triazole-CH 2-), 0.97 (9H, s ,-C (CH 3) 3)
IR(cm -1,KBr):3341,3098,2970,2806,1615,1588,1559,1272,1102,1060
Embodiment 2
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-p-methoxy-phenyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.39g (5mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 0.96g (5mmol) 1-[4-(4-methoxyl group) phenyl] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, heated and stirred 7h in 90 ℃ of water-baths, in the impouring 100ml water, ethyl acetate extraction (30ml * 3), washing, anhydrous sodium sulfate drying reclaims solvent, gets solid, use re-crystallizing in ethyl acetate, white, needle-shaped crystals 0.83g, yield: 55.63%, mp:110~111 ℃.
1H-NMR (DMSO-d 6) δ, ppm:7.94,8.48 (2H, s, s, triazole-H), 6.77~6.84 (4H, m, Ar-H), 4.53 (1H, s, OH), 4.32 (2H, s ,-CH 2-), 3.67 (3H, s ,-OCH 3), 2.29-2.88 (10H, m, piperazine-H ,-CH 2-), 0.91 (9H, s ,-C (CH 3) 3)
IR(cm -1,KBr):3120,3042,2959,2910,2880,2833,1511,1242,1182,1140,1036,817
Embodiment 3
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-ethoxyl phenenyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.39g (5mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.03g (5mmol) 1-[4-(4-oxyethyl group) phenyl] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, the operation steps of press embodiment 2 must white crystals 1.17g, yield: 60.5%, mp:78~80 ℃.
1H-NMR (DMSO-d 6) δ, ppm:7.94,848 (2H, s, s, triazole-H), 6.76~6.82 (4H, m, Ar-H), 4.52 (1H, s, OH), 4.32 (2H, s ,-CH 2-), 3.93 (2H, q, J=7.0Hz ,-OCH 2-), 2.27-2.88 (10H, m, piperazine-H ,-CH 2-), 1.28 (3H, t, J=70Hz ,-CH 3), 0.91 (9H, s ,-C (CH 3) 3)
Embodiment 4
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-pentyloxy phenyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.39g (5mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.24g (5mmol) 1-[4-(4-pentyloxy) phenyl] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, the operation steps of press embodiment 2 must white crystals 1.11g, yield: 51.7%, mp:120~123 ℃.
1H-NMR (DMSO-d 6) δ, ppm:7.94,8.48 (2H, s, s, triazole-H), 6.75~6.81 (4H, m, Ar-H), 4.43 (1H, s, OH), 4.32 (2H, s ,-CH 2-), 3.93 (2H, t, J=7.0Hz ,-OCH 2-), 2.29-2.89 (10H, m, piperazine-H ,-CH 2-), 1.20~1.22 (8H, m, 4X-CH 2-), 0.91 (12H, s, s ,-CH 3,-C (CH 3) 3)
Embodiment 5
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-isopropyl phenyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.39g (5mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.10g (5mmol) 1-[4-(4-isopropoxy) phenyl] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, the operation steps of press embodiment 2 must white crystals 0.98g, yield: 48.9%, mp:49~52 ℃.
1H-NMR (DMSO-d 6) δ, ppm:7.92,8.47 (2H, s, s, triazole-H), 6.76~6.82 (4H, m, Ar-H), 4.50 (1H, s, OH), 4.33 (2H, s ,-CH 2-), 3.85~388 (1H, m ,-CH-), 2.30-2.89 (10H, m, piperazine-H ,-CH 2-), 0.92 (15H, m, 2X-CH 3,-C (CH 3) 3)
Embodiment 6
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-benzyloxy phenyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.39g (5mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.34g (5mmol) 1-[4-(4-benzyloxy) phenyl] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, the operation steps of press embodiment 2 must white crystals 1.30g, yield: 57.9%, mp:139~141 ℃.
1H-NMR (DMSO-d 6) δ, ppm:7.92,8.46 (2H, s, s, triazole-H), 7.30~7.41 (5H, m, Ar-H), 6.81~6.89 (4H, m, Ar-H), 5.02 (2H, s ,-CH 2-), 4.48 (1H, s, OH), 4.33 (2H, s ,-CH 2-), 2.33-2.90 (10H, m, piperazine-H ,-CH 2-), 0.92 (9H, s ,-C (CH 3) 3)
IR(cm -1,KBr):3124,2963,2880,2826,1510,1240,1180,1137,1020,818
Embodiment 7
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-is to methyl benzyloxy phenyl) piperazine-L-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.39g (5mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.41g (5mmol) 1-[4-(4-is to the methyl benzyloxy) phenyl] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, the operation steps of press embodiment 2 must white crystals 1.37g, yield: 59.2%, mp:133~135 ℃.
1H-NMR (DMSO-d 6) δ, ppm:7.94,8.48 (2H, s, s, triazole-H), 7.16~7.30 (4H, d, d, J=8.0Hz, J=80Hz, Ar-H), 6.79~6.86 (4H, m, Ar-H), 496 (2H, s ,-CH 2-), 4.52 (1H, s, OH), 4.32 (2H, s ,-CH 2-), 2.30-2.89 (13H, m, piperazine-H ,-CH 2-,-CH 3), 0.91 (9H, s ,-C (CH 3) 3)
Embodiment 8
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-adjacent methyl benzyloxy phenyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.39g (5mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.41g (5mmol) 1-[4-(the adjacent methyl benzyloxy of 4-) phenyl] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, the operation steps of press embodiment 2 must white crystals 1.02g, yield: 44.1%, mp:115~117 ℃.
1H-NMR (DMSO-d 6) δ, ppm:7.94,8.48 (2H, s, s, triazole-H), 717~7.38 (4H, m, Ar-H), 6.82~6.90 (4H, m, Ar-H), 4.99 (2H, s ,-CH 2-), 4.53 (1H, s ,-OH), 4.32 (2H, s ,-CH 2-), 2.28-2.90 (13H, m, piperazine-H ,-CH 2-,-CH 3), 0.91 (9H, s ,-C (CH 3) 3)
Embodiment 9
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-(pyridine-4-methoxyl group) phenyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.39g (5mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.35g (5mmol) 1-[4-(4-(pyridine-4-methoxyl group) phenyl)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, the operation steps of press embodiment 2 must white crystals 0.93g, yield: 41.3%, mp:84~86 ℃.
1H-NMR (DMSO-d 6) δ, ppm:7.94,8.48 (2H, s, s, triazole-H), 7.39~7.40,8.55~8.56 (4H, m, m, Py-H), 6.81~6.89 (4H, m, Ar-H), 5.08 (2H, s ,-CH 2-), 4.52 (1H, s ,-OH), 4.32 (2H, s ,-CH 2-), 2.28-2.89 (10H, m, piperazine-H ,-CH 2-), 0.91 (9H, s ,-C (CH 3) 3)
IR(cm -1,KBr):3121,2959,2878,2822,1605,1511,1247,1184,1137,1093,1054,817
Embodiment 10
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-(pyridine-2-methoxyl group) phenyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.39g (5mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.35g (5mmol) 1-[4-(4-(pyridine-2-methoxyl group) phenyl)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, the operation steps of press embodiment 2 must white crystals 0.71g, yield: 31.6%, mp:122~124 ℃.
1H-NMR (DMSO-d 6) δ, ppm:7.94,8.48 (2H, s, s, triazole-H), 7.31~8.56 (4H, m, Py-H), 6.81~6.89 (4H, m, Ar-H), 5.08 (2H, s ,-CH 2-), 4.52 (1H, s ,-OH), 4.32 (2H, s ,-CH 2-), 2.29-2.90 (10H, m, piperazine-H ,-CH 2-), 0.91 (9H, s ,-C (CH 3) 3)
Embodiment 11
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-(pyridine-3-methoxyl group) phenyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.39g (5mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.35g (5mmol) 1-[4-(4-(pyridine-3-methoxyl group) phenyl)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, the operation steps of press embodiment 2 must white crystals 0.70g, yield: 31.1%, mp:122~124 ℃.
1H-NMR (DMSO-d 6) δ, ppm:7.94,8.48 (2H, s, s, triazole-H), 7.38~8.63 (4H, m, Py-H), 6.82~6.90 (4H, m, Ar-H), 5.06 (2H, s ,-CH 2-), 4.52 (1H, s ,-OH), 4.32 (2H, s ,-CH 2-), 2.29-2.90 (10H, m, piperazine-H ,-CH 2-), 0.91 (9H, s ,-C (CH 3) 3)
Embodiment 12
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-is to fluorine benzyloxy phenyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.39g (5mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.43g (5mmol) 1-[4-(4-is to fluorine benzyloxy phenyl)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, the operation steps of press embodiment 2 must white crystals 0.74g, yield: 31.6%, mp:110~112 ℃.
1H-NMR (DMSO-d 6) δ, ppm:7.94,8.48 (2H, s, s, triazole-H), 7.44~7.48,7.17~7.21 (4H, m, Ar-H), 6.81~6.87 (4H, m, Ar-H), 4.99 (2H, s ,-CH 2-), 4.53 (1H, s ,-OH), 4.32 (2H, s ,-CH 2-), 2.28-2.89 (10H, m, piperazine-H ,-CH 2-), 0.90 (9H, s ,-C (CH 3) 3)
Embodiment 13
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-adjacent fluorine benzyloxy phenyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.39g (5mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.43g (5mmol) 1-[4-(the adjacent fluorine benzyloxy of 4-phenyl)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, the operation steps of press embodiment 2 must white crystals 0.75g, yield: 32.1%, mp:128~130 ℃.
1H-NMR (DMSO-d 6) δ, ppm:7.95,8.49 (2H, s, s, triazole-H), 7.52,7.39~7.40,7.20~7.23 (4H, m, Ar-H), 6.82~6.90 (4H, m, Ar-H), 5.05 (2H, s ,-CH 2-), 4.53 (1H, s ,-OH), 4.32 (2H, s ,-CH 2-), 2.29-2.90 (10H, m, piperazine-H ,-CH 2-), 0.90 (9H, s ,-C (CH 3) 3)
Embodiment 14
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-is to chlorine benzyloxy phenyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.39g (5mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.52g (5mmol) 1-[4-(4-is to chlorine benzyloxy phenyl)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, the operation steps of press embodiment 2 must white crystals 0.86g, yield: 35.6%, mp:143~145 ℃.
1H-NMR (DMSO-d 6) δ, ppm:794,848 (2H, s, s, triazole-H), 7.43 (4H, m, Ar-H), 6.80~6.87 (4H, m, Ar-H), 5.01 (2H, s ,-CH 2-), 4.52 (1H, s ,-OH), 4.32 (2H, s ,-CH 2-), 2.28-2.61 (10H, m, piperazine-H ,-CH 2-), 0.90 (9H, s ,-C (CH 3) 3)
Embodiment 15
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-m-chloro benzyloxy phenyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.39g (5mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.52g (5mmol) 1-[4-(4-m-chloro benzyloxy phenyl)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, the operation steps of press embodiment 2 must white crystals 0.76g, yield: 31.4%, mp:110~112 ℃.
1H-NMR (DMSO-d 6) δ, ppm:7.94,8.48 (2H, s, s, triazole-H), 7.35~8.47 (4H, m, Ar-H), 6.82~6.88 (4H, m, Ar-H), 5.03 (2H, s ,-CH 2-), 4.53 (1H, s ,-OH), 4.32 (2H, s ,-CH 2-), 2.28-2.88 (10H, m, piperazine-H ,-CH 2-), 0.90 (9H, s ,-C (CH 3) 3)
Embodiment 16
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-(2, the 4-dichloro-benzyloxy) phenyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.39g (5mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.69g (5mmol) (4-(2 for 1-[4-, the 4-dichloro-benzyloxy) piperazine phenyl)], 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, press the operation steps of embodiment 2, white crystals 0.40g, yield: 15.4%, mp:102~105 ℃.
1H-NMR (DMSO-d 6) δ, ppm:7.94,8.48 (2H, s, s, triazole-H), 7.43~8.64 (4H, m, Ar-H), 6.82~6.90 (4H, m, Ar-H), 5.06 (2H, s ,-CH 2-), 4.51 (1H, s ,-OH), 4.32 (2H, s ,-CH 2-), 2.27-2.90 (10H, m, piperazine-H ,-CH 2-), 0.90 (9H, s ,-C (CH 3) 3)
Embodiment 17
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-is to methoxyl group benzyloxy base phenyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.39g (5mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.49g (5mmol) 1-[4-(4-is to methoxyl group benzyloxy base phenyl)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, the operation steps of press embodiment 2 must white crystals 1.49g, yield: 62.2%, mp:139~141 ℃.
1H-NMR (DMSO-d 6) δ, ppm:7.95,8.49 (2H, s, s, triazole-H), 7.33,6.92 (4H, d, d, J=8.0Hz, J=80Hz, Ar-H), 6.83 (4H, d, d, J=8.6Hz, J=8.6Hz, Ar-H), 4.92 (2H, s ,-CH 2-), 4.53 (1H, s ,-OH), 4.32 (2H, s ,-CH 2-), 3.75 (3H, s ,-OCH 3), 2.28-2.89 (10H, m, piperazine-H ,-CH 2-), 0.90 (9H, s ,-C (CH 3) 3)
Embodiment 18
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(2, the 4-dichloro benzyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.11g (4mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.18g (5mmol) 1-(2, the 4-dichloro benzyl) piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and anhydrous 30ml ethanol, heated and stirred 8h in 90 ℃ of water-baths filters, and reclaims ethanol, add water 50ml, filter,, get white crystals 0.42g with ethyl acetate-sherwood oil recrystallization, yield: 24.65%, mp:70~71 ℃.
1H-NMR (DMSO-d 6) δ, ppm:8.45,7.92 (2H, s, s, triazole-H), 7.37~7.54 (3H, m, Ar-H), 4.52 (1H, s ,-OH), 4.29 (2H, s ,-CH 2-), 3.48 (2H, s ,-CH 2-), 2.13-2.51 (10H, m, piperazine-H ,-CH 2-), 0.89 (9H, s ,-C (CH 3) 3)
IR(cm -1,KBr):3429,3259,2982,1616,1545,1257,1234,1210
Embodiment 19
Synthesizing of 1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-(4-benzyl diethylenediamine-1-yl)-2-propyl alcohol
In the 100ml three-necked bottle, add 1.11g (4mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 0.88g (5mmol) 1-(4-benzyl) piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and anhydrous 30ml ethanol, the operation steps of press embodiment 18 must white crystals 1.05g, yield: 73.5%, mp:99~101 ℃.
1H-NMR (DMSO-d 6) δ, ppm:8.45,7.92 (2H, s, s, triazole-H), 7.22~7.30 (5H, m, Ar-H), 4.56 (1H, s ,-OH), 4.27 (2H, s ,-CH 2-), 3.39 (2H, s ,-CH 2-), 2.10-2.24 (10H, m, piperazine-H ,-CH 2-), 0.87 (9H, s ,-C (CH 3) 3)
IR(cm -1,KBr):3398,3287,2946,1617,1548,1379,1266,1224
Embodiment 20
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(p-chlorobenzyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.11g (4mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.05g (5mmol) 1-(4-p-chlorobenzyl) piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and anhydrous 30ml ethanol, the operation steps of press embodiment 18 must white crystals 0.87g, yield: 55.6%, mp:130~133 ℃.
1H-NMR (DMSO-d 6) δ, ppm:8.24,7.82 (2H, s, s, triazole-H), 6.98~7.27 (4H, m, Ar-H), 5.27 (1H, s ,-OH), 4.58 (2H, s ,-CH 2-), 3.62 (2H, s ,-CH 2-), 2.22-2.53 (10H, m, piperazine-H ,-CH 2-), 0.95 (9H, s ,-C (CH 3) 3)
IR(cm -1,KBr):3431,3148,2935,1621,1530,1340,1208,1148
Embodiment 21
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(to methyl-benzyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.11g (4mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 0.95g (5mmol) 1-(4-is to methyl-benzyl) piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and anhydrous 30ml ethanol, press the operation steps of embodiment 18, get oily matter 1.16g, yield: 78.2%.
1H-NMR (DMSO-d 6) δ, ppm:8.05,7.87 (2H, s, s, triazole-H), 7.10~7.26 (4H, q, Ar-H), 4.65 (1H, s ,-OH), 4.47 (2H, s ,-CH 2-), 3.46 (2H, s ,-CH 2-), 2.54 (3H, s ,-CH 3), 2.23-2.42 (10H, m, piperazine-H ,-CH 2-), 0.99 (9H, s ,-C (CH 3) 3)
IR(cm -1,KBr):3410,3157,3086,1618,1591,1431,1268,1114
Embodiment 22
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(adjacent methyl-benzyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.11g (4mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 0.95g (5mmol) 1-(the adjacent methyl-benzyl of 4-) piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and anhydrous 30ml ethanol, the operation steps of press embodiment 18 must white crystals 0.97g, yield: 65.4%, mp:84~88 ℃.
1H-NMR (DMSO-d 6) δ, ppm:8.27,7.84 (2H, s, s, triazole-H), 7.09~7.26 (4H, m, Ar-H), 5.13 (1H, s ,-OH), 426 (2H, s ,-CH 2-), 335 (2H, s ,-CH 2-), 2.54 (3H, s ,-CH 3), 2.30 (10H, bs, piperazine-H ,-CH 2-), 0.98 (9H, s ,-C (CH 3) 3)
IR(cm -1,KBr):3425,3328,2941,1608,1540,1328,1286,1210
Embodiment 23
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(3, the 4-dichloro benzyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.11g (4mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.16g (5mmol) 1-[4-(3, the 4-dichloro benzyl)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and anhydrous 30ml ethanol, press the operation steps of embodiment 18, white crystals 1.08g, yield: 63.4%, mp:67~69 ℃.
1H-NMR (DMSO-d 6) δ, ppm:8.44,7.91 (2H, s, s, triazole-H), 7.49~7.56 (2H, m, Ar-H), 7.24~7.27 (1H, m, Ar-H), 4.53 (1H, s ,-OH), 4.27 (2H, s ,-CH 2-), 3.40 (2H, s ,-CH 2-), 2.12~2.50 (10H, m, piperazine-H ,-CH 2-), 0.98 (9H, s ,-C (CH 3) 3)
Embodiment 24
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(to luorobenzyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.11g (4mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 0.97g (5mmol) 1-[4-(4-luorobenzyl)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and anhydrous 30ml ethanol, the operation steps of press embodiment 18 must white crystals 0.93g, yield: 62.0%, mp:101~101.7 ℃.
1H-NMR (DMSO-d 6) δ, ppm:8.45,7.92 (2H, s, s, triazole-H), 7.27~7.31 (2H, m, Ar-H), 7.09~7.14 (2H, m, Ar-H), 4.55 (1H, s ,-OH), 428 (2H, s ,-CH 2-), 3.38 (2H, s ,-CH 2-), 2.11~2.52 (10H, m, piperazine-H ,-CH 2-), 0.88 (9H, s ,-C (CH 3) 3)
Embodiment 25
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(to methoxybenzyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.11g (4mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.03g (5mmol) 1-[4-(4-methoxybenzyl)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and anhydrous 30ml ethanol, the operation steps of press embodiment 18 must white crystals 0.78g, yield: 50.4%, mp:88~93 ℃.
1H-NMR (DMSO-d 6) δ, ppm:8.44,7.91 (2H, s, s, triazole-H), 7.15,6.85 (4H, d, d, J=8.4Hz, J=8.4Hz, Ar-H), 4.55 (1H, s ,-OH), 4.27 (2H, s ,-CH 2-), 3.73 (3H, s ,-CH 3), 3.32 (2H, s ,-CH 2-), 2.09~2.51 (10H, m, piperazine-H ,-CH 2-), 0.88 (9H, s ,-C (CH 3) 3)
Embodiment 26
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(m-chloro benzyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.11g (4mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.06g (5mmol) 1-[4-(3-benzyl chloride base)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and anhydrous 30ml ethanol, press the operation steps of embodiment 18, get oily matter 1.03g, yield: 65.8%.
1H-NMR (DMSO-d 6) δ, ppm:8.44,7.90 (2H, s, s, triazole-H), 7.20~7.33 (4H, m, Ar-H), 4.55 (1H, bs ,-OH), 4.27 (2H, s ,-CH 2-), 3.39 (2H, s ,-CH 2-), 2.10~2.50 (10H, m, piperazine-H ,-CH 2-), 0.88 (9H, s ,-C (CH 3) 3)
Embodiment 27
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(adjacent luorobenzyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.11g (4mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 0.97g (5mmol) 1-[4-(2-luorobenzyl)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and anhydrous 30ml ethanol, press the operation steps of embodiment 18, get oily matter 0.96g, yield: 64.0%.
1H-NMR (DMSO-d 6) δ, ppm:8.44,7.90 (2H, s, s, triazole-H), 7.27~7.36 (2H, m, Ar-H), 7.09~7.16 (2H, m, Ar-H), 4.53 (1H, bs ,-OH), 4.27 (2H, s ,-CH 2-), 3.45 (2H, s ,-CH 2-), 2.09~2.50 (10H, m, piperazine-H ,-CH 2-), 0.88 (9H, s ,-C (CH 3) 3)
Embodiment 28
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(2, the 6-dichloro benzyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.11g (4mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.16g (5mmol) 1-[4-(2, the 6-dichloro benzyl)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and anhydrous 30ml ethanol, press the operation steps of embodiment 18, white crystals 0.69g, yield: 40.5%, mp:73~77 ℃.
1H-NMR (DMSO-d 6) δ, ppm:8.45,7.91 (2H, s, s, triazole-H), 7.38~7.44 (2H, m, Ar-H), 7.25~7.31 (1H, m, Ar-H), 4.53 (1H, s ,-OH), 4.28 (2H, s ,-CH 2-), 3.49 (2H, s ,-CH 2-), 2.13~2.51 (10H, m, piperazine-H ,-CH 2-), 0.88 (9H, s ,-C (CH 3) 3)
Embodiment 29
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(to nitrobenzyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.11g (4mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.11g (5mmol) 1-[4-(4-nitrobenzyl)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and anhydrous 30ml ethanol, the operation steps of press embodiment 18 must white crystals 1.30g, yield: 80.8%, mp:100~102 ℃.
1H-NMR (DMSO-d 6) δ, ppm:8.42,7.89 (2H, s, s, triazole-H), 8.14,7.54 (4H, d, d, J=8.0Hz, J=8.0Hz, Ar-H), 4.48 (1H, bs ,-OH), 4.28 (2H, s ,-CH 2-), 3.54 (2H, s ,-CH 2-), 2.16~2.50 (10H, m, piperazine-H ,-CH 2-), 0.89 (9H, s ,-C (CH 3) 3)
Embodiment 30
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(to the cyano group benzyl) piperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.11g (4mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.01g (5mmol) 1-[4-(4-cyano group benzyl)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and anhydrous 30ml ethanol, the operation steps of press embodiment 18 must white crystals 1.26g, yield: 82.5%, mp:104~107 ℃.
1H-NMR (DMSO-d 6) δ, ppm:8.44,7.91 (2H, s, s, triazole-H), 7.75,7.46 (4H, d, d, J=8.0Hz, J=8.0Hz, Ar-H), 4.52 (1H, bs ,-OH), 4.28 (2H, s ,-CH 2-), 3.49 (2H, s ,-CH 2-), 2.13~2.50 (10H, m, piperazine-H ,-CH 2-), 0.88 (9H, s ,-C (CH 3) 3)
Embodiment 31
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(1-(benzimidazolyl-2 radicals-yl) methyl) piperazine-1-yl)-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 1.11g (4mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.08g (5mmol) 1-[4-(1-(benzimidazolyl-2 radicals-yl) methyl)] piperazine, 1.38g (10mmol) salt of wormwood, cetyl trimethylammonium bromide a little and anhydrous 30ml ethanol, the operation steps of press embodiment 18 must white crystals 1.43g, yield: 90.1%, mp:79~85 ℃.
1H-NMR (DMSO-d 6) δ, ppm:8.26,7.85 (3H, s, s, triazole-H, benzoglyoxaline-NH), 7.21~, 7.70 (4H, m, Ar-H), 4.62 (1H, bs ,-OH), 4.29 (2H, s ,-CH 2-), 3.70 (2H, s ,-CH 2-), 2.39~2.59 (10H, m, piperazine-H ,-CH 2-), 0.98 (9H, s ,-C (CH 3) 3)
Embodiment 32
Synthesizing of 1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-benzamido group-2-propyl alcohol
In the 100ml three-necked bottle, add 3.4g (12mmol) 1-(1H-1 successively, 2, the 4-triazol-1-yl)-and the 2-tertiary butyl-2,3-propylene oxide methane sulfonates, 1.1g (10mmol) benzylamine, 4.4g (32mmol) Anhydrous potassium carbonate, cetyl trimethylammonium bromide a little and 30ml dehydrated alcohol, heated and stirred 7h in 90 ℃ of water-baths filters, reclaim ethanol, add 50ml water, filter, with ethyl acetate extraction (50ml * 3), dry, reclaim solvent, column chromatography gets colorless oil, heavy 0.5g, yield: 17.65%.
1H-NMR(DMSO-d 6)δ,ppm:8.21,7.89(2H,s,s,triazole-H),7.22~7.30(3H,m,Ar-H),7.11~7.13(2H,m,Ar-H),4.27(2H,s,-CH 2-),3.56(2H,s,-CH 2-),2.92,2.64(4H,d,d,J=13.2Hz,J=13.2Hz,-CH 2-),0.96(9H,s,-C(CH 3) 3)
Embodiment 33
Synthesizing of 1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-piperazine-2-propyl alcohol
Get 2.7g (0.015mol) epoxide free alkali, it is 1-(1H-1,2,4-triazol-1-yl)-2-tertiary butyl-2, the 3-propylene oxide, 12.9g (0.15mol) Piperazine anhydrous and 40ml dehydrated alcohol are put into the 100ml three-necked bottle, reflux 6h reclaims ethanol, add 30ml water, piperazine is removed in underpressure distillation, adds 50ml chloroform, washing (20ml * 3) in residuum, anhydrous sodium sulfate drying, reclaim solvent, the adularescent solid is separated out, re-crystallizing in ethyl acetate, get the white powder solid, heavy 2.1g, yield 52.43%, mp:96~98 ℃.
1H-NMR (DMSO-d 6) δ, ppm:8.45,7.93 (2H, s, s, triazole-H), 4.63 (1H, bs ,-OH), 4.27 (2H, dd ,-CH 2-), 2.34~2.54 (8H, m, piperazine-H), 1.97 (2H, dd ,-CH 2-), 0.88 (9H, s ,-C (CH 3) 3)
Embodiment 34
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-anisole amido) formyl methylpiperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 2.8g (10mmol) 1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-piperazine-2-propyl alcohol, 2.2g (11mmol) to the methoxychlor Acetanilide, 2.5g (18mmol) Anhydrous potassium carbonate and 50ml toluene, backflow 6h, placement is spent the night, and has solid to separate out, and filters, dry, with ethyl acetate-sherwood oil recrystallization, get white solid, heavy 3.2g, yield 74.4%, mp:86~89 ℃.
1H-NMR (DMS0-d 6) δ, ppm:9.43 (1H, s ,-NH-), 8.47,7.94 (2H, s, s, triazole-H), 7.49~7.52 (2H, m, Ar-H), 6.86~6.88 (2H, m, Ar-H), 4.54 (1H, s ,-OH), 4.30 (2H, s ,-CH 2-), 3.73 (3H, s ,-CH 3), 3.03 (2H, s ,-CH 2-), 2.21~2.53 (8H, piperazine-H), 0.90 (9H, s ,-C (CH 3) 3)
Embodiment 35
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(3-toluidine) formyl methylpiperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 2.8g (10mmol) 1-(1H-1,2, the 4-triazol-1-yl)-the 2-tertiary butyl-3-piperazine-2-propyl alcohol, 2.02g (11mmol) 3-methyl chloride Acetanilide, 2.5g (18mmol) Anhydrous potassium carbonate and 50ml toluene, the operation steps of pressing embodiment 34, get white solid, heavy 2.70g, yield 65.2%, mp:141~143 ℃.
1H-NMR (DMSO-d 6) δ, ppm:9.50 (1H, bs ,-NH-), 8.48,7.95 (2H, s, s, triazole-H), 7.41~744,7.17~7.21,6.88~6.90 (4H, m, Ar-H), 4.55 (1H, s ,-OH), 4.31 (2H, s ,-CH 2-), 3.06 (2H, s ,-CH 2-), 2.23~2.55 (13H, piperazine-H ,-CH 2-,-CH 3), 0.92 (9H, s ,-C (CH 3) 3)
Embodiment 36
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-toluidine) formyl methylpiperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 2.8g (10mmol) 1-(1H-1,2, the 4-triazol-1-yl)-the 2-tertiary butyl-3-piperazine-2-propyl alcohol, 2.02g (11mmol) 4-methyl chloride Acetanilide, 2.5g (18mmol) Anhydrous potassium carbonate and 50ml toluene, the operation steps of pressing embodiment 34, get white solid, heavy 2.72g, yield 65.7%, mp:84~88 ℃.
1H-NMR (DMSO-d 6) δ, ppm:9.46 (1H, bs ,-NH-), 8.45,7.92 (2H, s, s, triazole-H), 7.46,7.09 (4H, d, d, J=8.8Hz, J=8.8Hz, Ar-H), 4.53 (1H, s ,-OH), 4.29 (2H, s ,-CH 2-), 3.02 (2H, s ,-CH 2-), 2.21~2.52 (13H, piperazine-H ,-CH 2-,-CH 3), 0.89 (9H, s ,-C (CH 3) 3)
Embodiment 37
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(3-chloroanilino) formyl methylpiperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 2.8g (10mmol) 1-(1H-1,2, the 4-triazol-1-yl)-the 2-tertiary butyl-3-piperazine-2-propyl alcohol, 2.24g (11mmol) 3-chlorine chloroacetanilide, 2.5g (18mmol) Anhydrous potassium carbonate and 50ml toluene, the operation steps of pressing embodiment 34, get white crystals, heavy 2.64g, yield 60.8%, mp:160~162 ℃.
1H-NMR (DMSO-d 6) δ, ppm:9.77 (1H, bs ,-NH-), 8.47,7.94 (2H, s, s, triazole-H), 7.51~7.53,7.30~7.34,7.09~7.11 (3H, m, Ar-H), 4.54 (1H, s ,-OH), 4.30 (2H, s ,-CH 2-), 3.07 (2H, s ,-CH 2-), 2.21~2.53 (10H, piperazine-H ,-CH 2-), 0.90 (9H, s ,-C (CH 3) 3)
Embodiment 38
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-benzamido group formyl methylpiperazine-1-yl] 1-2-propyl alcohol nitrate synthetic
In the 100ml three-necked bottle, add 2.8g (10mmol) 1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-piperazine-2-propyl alcohol, 2.02g (11mmol) chloracetyl benzylamine, 2.5g (18mmol) Anhydrous potassium carbonate and 50ml toluene, backflow 6h, placement is spent the night, and reclaims toluene, uses the 50ml acetic acid ethyl dissolution, under agitation drip the 1ml concentrated nitric acid, continue to stir 1h, filter out solid, drying is used the dehydrated alcohol recrystallization, gets white solid 3.2g, yield 75.3%, mp:127~129 ℃.
1H-NMR (DMSO-d 6) δ, ppm:8.71,8.18 (2H, s, s, triazole-H), 7.28~7.34 (5H, m, Ar-H), 4.94 (1H, bs ,-OH), 449 (2H, q ,-CH 2-), 4.38 (2H, s ,-CH 2-), 4.01 (2H, s ,-CH 2-), 3.37~3.51 (10H, piperazine-H ,-CH 2-), 0.93 (9H, s ,-C (CH 3) 3
Embodiment 39
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-anilino formyl methylpiperazine-1-yl]-2-propyl alcohol nitrate synthetic
In the 100ml three-necked bottle, add 2.8g (10mmol) 1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-piperazine-2-propyl alcohol, 1.87g (11mmol) chloroacetanilide, 2.5g (18mmol) Anhydrous potassium carbonate and 50ml toluene, backflow 6h, placement is spent the night, and reclaims toluene, uses the 50ml acetic acid ethyl dissolution, under agitation drip the 1ml concentrated nitric acid, continue to stir 1h, filter out solid, drying is used the dehydrated alcohol recrystallization, gets white solid 3.1g, yield 65.0%, mp:130~132 ℃.
1H-NMR (DMSO-d 6) δ, ppm:10.52 (1H, bs ,-NH-), 8.75,8.18 (2H, s, s, triazole-H), 7.59~7.60,7.35~7.39,7.11~7.16 (5H, m, Ar-H), 494 (1H, bs ,-OH), 4.49 (2H, q ,-CH 2-), 3.81 (2H, s ,-CH 2-), 3.41~3.56 (10H, piperazine-H ,-CH 2-), 0.92 (9H, s ,-C (CH 3) 3)
Embodiment 40
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-chloroanilino) formyl methylpiperazine-1-yl]-2-propyl alcohol nitrate synthetic
In the 100ml three-necked bottle, add 2.8g (10mmol) 1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-piperazine-2-propyl alcohol, 2.24g (11mmol) 4-chlorine chloroacetanilide, 2.5g (18mmol) Anhydrous potassium carbonate and 50ml toluene, backflow 6h, placement is spent the night, and reclaims toluene, uses the 50ml acetic acid ethyl dissolution, under agitation drip the 1ml concentrated nitric acid, continue to stir 1h, filter the mountain solid, drying is used the dehydrated alcohol recrystallization, gets white solid 3.1g, yield 62.3%, mp:141~143 ℃.
1H-NMR (DMSO-d 6) δ, ppm:8.61,8.10 (2H, s, s, triazole-H), 7.58,7.39 (4H, d, d, J=8.8Hz, J=8.8Hz, Ar-H), 4.45 (2H, q ,-CH 2-), 3.88 (2H, s ,-CH 2-), 3.19~3.30 (10H, piperazine-H ,-CH 2-), 0.92 (9H, s ,-C (CH 3) 3)
Embodiment 41
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-phenetole amido) formyl methylpiperazine-1-yl]-2-propyl alcohol nitrate synthetic
In the 100ml three-necked bottle, add 2.8g (10mmol) 1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-piperazine-2-propyl alcohol, 2.35g (11mmol) 4-oxyethyl group chloroacetanilide, 2.5g (18mmol) Anhydrous potassium carbonate and 50ml toluene, backflow 6h, placement is spent the night, and reclaims toluene, uses the 50ml acetic acid ethyl dissolution, under agitation drip the 1ml concentrated nitric acid, continue to stir 1h, filter out solid, drying is used the dehydrated alcohol recrystallization, gets white solid 3.27g, yield 64.5%, mp: greater than 250 ℃.
1H-NMR (DMSO-d 6) δ, ppm:10.26 (1H, bs ,-NH-), 8.68,8.16 (2H, s, s, triazole-H), 7.47,6.92 (4H, d, d, J=8.8Hz, J=8.8Hz, Ar-H), 4.49 (2H, q ,-CH 2-), 3.98~4.05 (4H, m, 2X-CH 2-), 3.37~3.50 (10H, piperazine-H ,-CH 2-), 1.31 (3H, t ,-CH 3), 0.92 (9H, s ,-C (CH 3) 3)
Embodiment 42
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(2,4 dichloro benzene amido) formyl methylpiperazine-1-yl]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add 2.8g (10mmol) 1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-piperazine-2-propyl alcohol, 2.62g (11mmol) 2,4-dichloro chloroacetanilide, 2.5g (18mmol) Anhydrous potassium carbonate and 50ml toluene, backflow 6h, placement is spent the night, and reclaims toluene, use the 50ml acetic acid ethyl dissolution, under agitation drip the 1ml concentrated nitric acid, continue to stir 1h, filter out solid, drying is used the dehydrated alcohol recrystallization, white solid 3.3g, yield 62.1%, mp:156~158 ℃.
1H-NMR (DMSO-d 6) δ, ppm:9.89 (1H, s ,-NH-), 8.49,7.96 (2H, s, s, triazole-H), 8.28~8.30,7.69,7.44~7.46 (3H, m, Ar-H), 4.51 (1H, s ,-OH), 4.33 (2H, s ,-CH 2-), 3.17 (2H, s ,-CH 2-), 2.28~2.60 (10H, piperazine-H ,-CH 2-), 0.92 (9H, s ,-C (CH 3) 3)
Embodiment 43
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-chloracetyl piperazine-1-yl]-2-propyl alcohol synthetic
In the 50ml three-necked bottle, add 1.3g (5mmol) 1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-piperazine-2-propyl alcohol, add the 10mlDMF dissolving, add 1g (10mml) triethylamine again, under condition of ice bath, slowly drip 1.1g (10mml) chloroacetyl chloride, stirring at room 1h pours in the 20ml frozen water, stirs, placement is spent the night, with ethyl acetate extraction (25ml * 3), saturated common salt washing, anhydrous sodium sulfate drying, filter, residue is directly used in next step reaction behind the recovery solvent.
Embodiment 44
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(2-1H-1,2,4-triazol-1-yl) acetylpiperazine-1-yl]-2-propyl alcohol synthetic
In the 50ml three-necked bottle, add 2.0g (6mmol) 1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-chloracetyl piperazine-1-yl]-the 2-propyl alcohol; 1.8g (18mmol) triethylamine; 1.2g (18mmol) 1,2,4-triazole and 25ml dehydrated alcohol; stirring at room 1h; reflux 7h reclaims ethanol, extracts (30ml * 3) with 5% hydrochloric acid soln; the acid layer alkalizes to pH10 with diluted sodium hydroxide solution; use ethyl acetate extraction (25ml * 3) again, anhydrous sodium sulfate drying filters; reclaim solvent and get solid; with ethyl acetate-sherwood oil recrystallization, get white solid, heavy 0.5g; yield 21.7%, mp:176~178 ℃.
1H-NMR (DMSO-d 6) δ, ppm:8.50,7.96; 8.39,7.91 (2H, s, s, triazole-H), 5.19 (2H, s ,-CH 2-), 4.48 (1H, s ,-OH), 4.33 (2H, s ,-CH 2-), 3.35 (2H, s ,-CH 2-), 2.21~251 (8H, piperazine-H), 0.89 (9H, s ,-C (CH 3) 3)
Embodiment 45
1-(1H-1,2,4-the triazol-1-yl)-2-tertiary butyl-3-[4-(4-acetylpiperazine-1-yl) phenoxy group]-2-propyl alcohol synthetic
In the 100ml three-necked bottle, add the 25ml dehydrated alcohol; 0.5g sodium Metal 99.5; make pure sodium solution; added 4.0g (18.2mmol) 4-(4-ethanoyl piperazine-1-yl) phenol, stirring at room again 30 minutes; add 2.9g (16mmol) 1-(1H-1,2,4-triazol-1-yl)-2-tertiary butyl-2; the 3-propylene oxide is dissolved in the solution of 15ml dehydrated alcohol, reflux 3 days.Cooling adds 8% sodium hydroxide solution 50ml, and with ethyl acetate extraction (50ml * 3), anhydrous sodium sulfate drying spends the night, filter, and column chromatography behind the recovery solvent, developping agent is an ethyl acetate, gets oily matter, heavy 2.5g, yield 38.97%.
1H-NMR (DMSO-d 6) δ, ppm:8.36,7.89 (2H, s, s, triazole-H), 6.88~6.90 (2H, m, Ar-H), 6.77~6.79 (2H, m, Ar-H), 4.71 (1H, s ,-OH), 4.28 (2H, s ,-CH 2-), 4.68,4.36 (2H, d, d, J=14.0Hz, J=14.0Hz ,-CH 2-), 3.80,3.49 (2H, d, d, J=9.6Hz, J=9.6Hz ,-CH 2-), 3.55~3.56,2.95~3.01 (8H, m, piperazine-H), 2.03 (3H, s ,-CH 3), 1.03 (9H, s ,-C (CH 3) 3)
Bacteriostatic test
Synthetic triazole class compounds of the present invention and its esters have antifungic action, its bacteriostatic experiment method and result are as follows: the antimycotic susceptibility experimental technique of stdn that adopts American National standard committee of clinical labororatory (NCCLS) to recommend is tested its extracorporeal antifungal activity, the concentration that suppresses selected fungi 80% growth with target compound is as judging terminal point (MIC80, reference: Antimicrob Agents Chemother 45 (9): 2420,2001).
One, materials and methods
1, experiment fungal bacterial strain
Two kinds of ATCC type strains and six kinds of clinical strains are selected in this research for use, the ATCC type strain is given by Shanghai City Long March hospital bacterial classification preservation center, clinical strain is provided by Changhai Hospital, Shanghai City's Mycology Lab, picks up from different section office of Changhai hospital clinical sample respectively, and through morphology and biochemical evaluation.
8 kinds of fungies comprise 4 kinds of deep fungals: Candida albicans (Candida albicans) ATCC76615, cryptococcus neoformans (Cryptococcus neoformans) ATCC32609, Oidium tropicale (Candida tropicalis), Candida parapsilosis (Candida parapsilosis), 3 kinds of superficial mycosiss: trichophyton (Trichophytonrubrum), wool sample sporidiole bacteria (Microsporum lauosum), fonsecaea compacta (Fonsecaea compacta) and smoke aspergillus fumigatus (Aspergillus fumigatus).
2, nutrient solution
RPMI1640 nutrient solution: RPMI1640 (Gibco BRL) 10g, NaHCO 32.0g, morphine quinoline propanesulfonic acid (morpholinepropanesulfonic acid, MOPS) (Sigma) 34.5g (0.165M) adds tri-distilled water 900ml dissolving, and 1N NaOH transfers pH to 7.0 (25 ℃), and is fixed molten to 1000ml, filters sterilization, 4 ℃ of preservations.
Husky fort glucose agar medium (SDA): peptone 10g, glucose 40g, agar 18g adds tri-distilled water 900ml dissolving, adds 2mg/ml chloramphenicol solution 50ml, adjusts pH to 7.0, and is fixed molten to 1000ml, 4 ℃ of preservations behind the autoclaving.
The YEPD nutrient solution: yeast extract 10g, peptone 20g, glucose 20g adds tri-distilled water 900ml dissolving, adds 2mg/ml chloramphenicol solution 50ml, and is fixed molten to 1000ml, 4 ℃ of preservations behind the autoclaving.
3, experimental technique
The preparation of bacterium liquid, soup, drug sensitive plate: operate by the standardized method that standard committee of American National clinical labororatory (NCCLS) proposes.
Two, the MIC value is judged
Candidiasis, cryptococcus neoformans and thread fungus are cultivated 24h, 72h and after the week, survey each hole OD value with enzyme micro-plate reader in 630nm respectively at 35 ℃.With the positive control boring ratio, be MIC80 (concentration when fungal growth 80% is suppressed) with the drug level in the minimum concentration hole of OD value decline more than 80%.
MIC when medicine 80Value surpasses when measuring concentration range, adds up by the following method: MIC 80When value is higher than maximum concentration 64mg/L, be designated as ">64mg/L "; MIC 80Value is not distinguished for minimum concentration or when minimum concentration is following, all is designated as "≤0.125mg/L ".
The equal parallel running of above-mentioned experiment 2 to 3 times is worked as MIC 80Value just is accepted in the time of accurately repeating or only differ from a concentration, and with higher concentration as MIC 80Value; Work as MIC 80Value differs two concentration when above, then needs experiment again, till meeting the requirements.
Three, result's (seeing Table 1)
The extracorporeal antifungal activity of table 1 part target compound
MIC 80(μg/ml)
Embodiment (compound) numbering Ca. Cp. Cn. Ct. Tr. Af. Ml. Fc.
3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 29 30 1 1 ≤0.125 ≤0.125 ≤0.125 ≤0.125 0.25 1 0.5 <0.125 <0.125 <0.125 <0.125 <0.125 <0.125 1 4 1 4 16 1 4 16 16 16 16 16 16 16 16 16 32 <0.125 <0.125 <0.125 <0.125 <0.125 <0.125 1 0.5 0.25 8 16 4 1 2 8 8 0.25 1 1 1 2 4 4 <0.125 <0.125 <0.125 <0.125 0.25 <0.125 >64 4 32 32 16 8 0.5 0.5 32 32 32 >64 >64 >64 32 32 32 <0.125 <0.125 <0.125 <0.125 <0.125 <0.125 0.5 32 16 16 16 8 0.5 2 0.5 0.5 ≤0.125 ≤0.125 ≤0.125 ≤0.125 0.5 1 1 0.125 0.125 0.125 0.125 0.25 0.125 0.125 0.25 0.125 0.125 0.5 0.5 1 0.25 32 32 2 4 4 4 8 32 16 1 16 8 4 2 1 8 16 8 16 32 16 8 8 ≤0.125 ≤0.125 ≤0.125 ≤0.125 ≤0.125 ≤0.125 0.5 0.5 0.5 <0.125 <0.125 0.5 <0.125 0.25 <0.125 0.125 0.125 0.125 0.125 0.25 0.125 1 1 2 2 2 8 8 8 1 2 2 0.125 0.125 0.125 0.125 1 0.125 0.5 1 0.25 1 0.5 0.25 0.5 0.25
32 4 0.25 1 0.5 0.125 8 0.25 0.125
34 0.125 0.25 <0.125 0.25 0.5 32 0.125 0.125
37 <0.125 0.125 <0.125 0.125 0.125 16 <0.125 0.125
38 8 32 8 16 0.125 32 4 8
40 <0.125 <0.125 <0.125 <0.125 0.125 16 0.5 0.125
42 <0.125 <0.125 <0.125 <0.125 0.125 1 <0.125 0.125
44 <0.125 <0.125 <0.125 <0.125 0.125 2 <0.125 0.5
45 <0.125 <0.125 <0.125 <0.125 0.125 1 <0.125 0.125
FLU 1 0.5 2 1 1 64 16 8
ITR <0.125 <0.125 <0.125 <0.125 0.125 1 <0.125 0.125
Annotate: Ca.=Candida albicans (Candida albicans) ATCC76615, Cp=Candida parapsilosis (Candidaparapsilosis), Cn.=cryptococcus neoformans (Cryptococcus neoformans) ATCC32609, Ct.=Oidium tropicale (Candida tropicalis), Tr.=trichophyton (Trichophyton rubrum), Af.=smokes aspergillus fumigatus (Aspergillusfumigatus), M1.=wool sample sporidiole bacteria (Microsporum lauosum), Fc.=fonsecaea compacta (Fonsecaea compacta).
FLU=fluconazole (fluconazole), ITR=itraconazole (itraconazole).
Above-mentioned experimental result shows that 2-alkyl substituted triazole compounds of the present invention has anti-mycotic activity preferably, most compounds all is better than fluconazole to the vitro inhibition activity of selected fungi, with itraconazole quite or more excellent, illustrate that The compounds of this invention and its esters can be used for preparing the medicine for the treatment of fungi infestation.

Claims (8)

1、一种新型烷基取代的三氮唑类抗真菌化合物,其化学结构通式为1-(1H-1,2,4-三唑-1-基)-2-烷基-3-取代-2-丙醇(I),1. A novel alkyl-substituted triazole antifungal compound whose general chemical structure is 1-(1H-1,2,4-triazol-1-yl)-2-alkyl-3-substituted -2-propanol (I),
Figure A2005100307460002C1
Figure A2005100307460002C1
其中R代表:where R stands for:
Figure A2005100307460002C2
Figure A2005100307460002C2
这里a,b,c分别为包括甲基、乙基、丙基、丁基、环丙基、环丁基、环戊基和环己基在内的含有1-6个碳原子的基团,可以相同,也可以不同。Here a, b, and c are respectively groups containing 1-6 carbon atoms including methyl, ethyl, propyl, butyl, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl, which can be Same or different.
2、按权利要求1所述的一种新型烷基取代的三氮唑类抗真菌化合物的各种对映异构体、非对映异构体、氮氧化物和前体药物,及包括盐酸盐、磷酸盐、甲烷磺酸盐在内的药用盐类。2. Various enantiomers, diastereoisomers, nitrogen oxides and prodrugs of a novel alkyl-substituted triazole antifungal compound according to claim 1, and salts thereof Medicinal salts including salts, phosphates, and methanesulfonates. 3、按权利要求1所述的一种新型烷基取代的三氮唑类抗真菌化合物I中:M代表氢或包括甲基、乙基、三氟甲基在内的1~4个碳原子基团,优选甲基。3. In a novel alkyl-substituted triazole antifungal compound I according to claim 1: M represents hydrogen or 1 to 4 carbon atoms including methyl, ethyl, and trifluoromethyl group, preferably methyl. 4、按权利要求1、2或3所述的一种新型烷基取代的三氮唑类抗真菌化合物I中:Z代表杂环或取代杂环:4. In a novel alkyl-substituted triazole antifungal compound I according to claim 1, 2 or 3: Z represents a heterocycle or a substituted heterocycle: 这里的杂环是指五员或六员杂环,选自呋喃、噻吩、吡唑、咪唑、三氮唑、四氮唑、噁唑、噻唑、异噁唑、吡啶、嘧啶、吡唑酮、氢化吡唑酮、2-咪唑啉酮、4,5-二氢咪唑啉酮、1,2,4-三唑-3-酮、哌嗪、吗啉和哌啶,杂环上取代基可位于杂环的各个位置,可以是单取代,也可以是多取代;取代基指:The heterocyclic ring here refers to a five-membered or six-membered heterocyclic ring selected from furan, thiophene, pyrazole, imidazole, triazole, tetrazole, oxazole, thiazole, isoxazole, pyridine, pyrimidine, pyrazolone, Hydrogenated pyrazolone, 2-imidazolinone, 4,5-dihydroimidazolinone, 1,2,4-triazol-3-one, piperazine, morpholine and piperidine, the substituent on the heterocycle can be located Each position of the heterocyclic ring can be mono-substituted or multi-substituted; the substituent refers to: 1)含有1-6个碳原子的基团,包括甲基、乙基、三氟甲基、羟甲基、甲氧甲基、乙氧甲基、异丙基和叔丁基;1) groups containing 1-6 carbon atoms, including methyl, ethyl, trifluoromethyl, hydroxymethyl, methoxymethyl, ethoxymethyl, isopropyl and tert-butyl; 2)卤素,包括F、Cl、Br、I;2) Halogen, including F, Cl, Br, I; 3)吸电子基团或供电子基团,包括甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N-甲基氨甲酰基、N-乙基氨甲酰基、N,N-二甲基氨甲酰基、N,N-二乙基氨甲酰基、甲氧酰基、乙氧酰基、氨基、乙酰氨基、羟基、甲氧基、乙氧基;3) Electron-withdrawing groups or electron-donating groups, including methylsulfone, methylsulfoxide, nitro, cyano, carbamoyl, N-methylcarbamoyl, N-ethylcarbamoyl, N, N-dimethylcarbamoyl, N,N-diethylcarbamoyl, methoxyl, ethoxyl, amino, acetamido, hydroxyl, methoxy, ethoxy; 4)对位取代苯乙烯基,苯环上的取代基为F、Cl、Br、I;甲砜基、甲亚砜基、甲基、乙基、三氟甲基、三氟甲氧基、四氟乙氧基、四氟丙氧基、甲氧甲基、异丙基和叔丁基。4) Para-substituted styryl, the substituents on the benzene ring are F, Cl, Br, I; methylsulfonyl, methylsulfoxide, methyl, ethyl, trifluoromethyl, trifluoromethoxy, Tetrafluoroethoxy, tetrafluoropropoxy, methoxymethyl, isopropyl and t-butyl. 5、按权利要求1、2或3所述的一种新型烷基取代的三氮唑类抗真菌化合物I中:Z代表取代稠合杂环:5. In a novel alkyl-substituted triazole antifungal compound I according to claim 1, 2 or 3: Z represents a substituted fused heterocyclic ring: 这里的稠合杂环是指苯环与五员或六员杂环稠合,五员或六员杂环选自呋喃、噻吩、吡唑、咪唑、三氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶和嘧啶,取代基可位于苯环上和杂环上,可以是单取代,也可以是多取代;取代基指:The fused heterocycle here refers to a benzene ring fused with a five-membered or six-membered heterocycle, and the five-membered or six-membered heterocycle is selected from furan, thiophene, pyrazole, imidazole, triazole, oxazole, thiazole, isoxa Azole, pyran, pyridine and pyrimidine, the substituent can be located on the benzene ring and the heterocyclic ring, and can be mono-substituted or multi-substituted; the substituent refers to: 1)含有1-6个碳原子的基团,包括甲基、乙基、三氟甲基、羟甲基、甲氧甲基、乙氧甲基、异丙基和叔丁基;1) groups containing 1-6 carbon atoms, including methyl, ethyl, trifluoromethyl, hydroxymethyl, methoxymethyl, ethoxymethyl, isopropyl and tert-butyl; 2)卤素,包括F、Cl、Br、I;2) Halogen, including F, Cl, Br, I; 3)吸电子基团或供电子基团,包括甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N-甲基氨甲酰基、N-乙基氨甲酰基、N,N-二甲基氨甲酰基、N,N-二乙基氨甲酰基、甲氧酰基、乙氧酰基、氨基、乙酰氨基、羟基、甲氧基、乙氧基;3) Electron-withdrawing groups or electron-donating groups, including methylsulfone, methylsulfoxide, nitro, cyano, carbamoyl, N-methylcarbamoyl, N-ethylcarbamoyl, N, N-dimethylcarbamoyl, N,N-diethylcarbamoyl, methoxyl, ethoxyl, amino, acetamido, hydroxyl, methoxy, ethoxy; 4)对位取代苯乙烯基,苯环上的取代基为F、Cl、Br、I;甲砜基、甲亚砜基、甲基、乙基、三氟甲基、三氟甲氧基、四氟乙氧基、四氟丙氧基、甲氧甲基、异丙基和叔丁基。4) Para-substituted styryl, the substituents on the benzene ring are F, Cl, Br, I; methylsulfonyl, methylsulfoxide, methyl, ethyl, trifluoromethyl, trifluoromethoxy, Tetrafluoroethoxy, tetrafluoropropoxy, methoxymethyl, isopropyl and t-butyl. 6、按权利要求1、2或3所述的一种新型烷基取代的三氮唑类抗真菌化合物I中:Z代表6. In a novel alkyl-substituted triazole antifungal compound I according to claim 1, 2 or 3: Z represents X-BX-B X为O、S、NH、SO、SO2;B为:X is O, S, NH, SO, SO2 ; B is: 1)含有1-6个碳原子的基团,包括甲基、乙基、三氟甲基、羟甲基、甲氧甲基、异丙基、环戊基和环己基;1) groups containing 1-6 carbon atoms, including methyl, ethyl, trifluoromethyl, hydroxymethyl, methoxymethyl, isopropyl, cyclopentyl and cyclohexyl; 2)取代苯基,这里的取代基为1-3个,可以相同也可以不同,包括F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基、叔丁基;甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N-甲基氨甲酰基、N-乙基氨甲酰基、N,N-二甲基氨甲酰基、N,N-二乙基氨甲酰基、甲氧酰基、乙氧酰基、氨基、乙酰氨基、羟基、甲氧基、乙氧基;2) Substituted phenyl, where the substituents are 1-3, which can be the same or different, including F, Cl, Br, I; methyl, ethyl, trifluoromethyl, isopropyl, tert-butyl; Methylsulfonyl, methylsulfoxide, nitro, cyano, carbamoyl, N-methylcarbamoyl, N-ethylcarbamoyl, N,N-dimethylcarbamoyl, N,N- Diethylcarbamoyl, methoxyl, ethoxyl, amino, acetamido, hydroxyl, methoxy, ethoxy; 3)取代杂环,这里的杂环是指五员或六员杂环,选自呋喃、噻吩、吡唑、咪唑、三氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶、嘧啶、吡唑酮、氢化吡唑酮、2-咪唑啉酮、4,5-二氢咪唑啉酮、1,2,4-三唑-3-酮、哌嗪、吗啉和哌啶,杂环上取代基可位于杂环的各个位置,可以是单取代,也可以是多取代,包括F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基、叔丁基;甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N-甲基氨甲酰基、N-乙基氨甲酰基、N,N-二甲基氨甲酰基、N,N-二乙基氨甲酰基、甲氧酰基、乙氧酰基、氨基、乙酰氨基、羟基、甲氧基、乙氧基;3) Substituted heterocycle, here heterocycle refers to five-membered or six-membered heterocycle, selected from furan, thiophene, pyrazole, imidazole, triazole, oxazole, thiazole, isoxazole, pyran, pyridine, pyrimidine , pyrazolone, hydrogenated pyrazolone, 2-imidazolinone, 4,5-dihydroimidazolinone, 1,2,4-triazol-3-one, piperazine, morpholine and piperidine, heterocyclic The upper substituent can be located at each position of the heterocycle, and can be mono-substituted or multi-substituted, including F, Cl, Br, I; methyl, ethyl, trifluoromethyl, isopropyl, tert-butyl; Methylsulfonyl, methylsulfoxide, nitro, cyano, carbamoyl, N-methylcarbamoyl, N-ethylcarbamoyl, N,N-dimethylcarbamoyl, N,N- Diethylcarbamoyl, methoxyl, ethoxyl, amino, acetamido, hydroxyl, methoxy, ethoxy; 4)取代芳香环甲基,这里的芳香环指常见的五员或六员芳香(杂)环,选自苯环、呋喃、噻吩、吡唑、咪唑、三氮唑、四氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶和嘧啶,芳香(杂)环上取代基可位于各个位置,可以是单取代,也可以是多取代,包括F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基、叔丁基;甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N-甲基氨甲酰基、N-乙基氨甲酰基、N,N-二甲基氨甲酰基、N,N-二乙基氨甲酰基、甲氧酰基、乙氧酰基、氨基、乙酰氨基、羟基、甲氧基、乙氧基。4) Substituted aromatic ring methyl, where the aromatic ring refers to a common five-membered or six-membered aromatic (hetero) ring, selected from benzene ring, furan, thiophene, pyrazole, imidazole, triazole, tetrazole, oxazole , thiazole, isoxazole, pyran, pyridine and pyrimidine, the substituents on the aromatic (hetero) ring can be located at various positions, and can be single or multiple substitutions, including F, Cl, Br, I; methyl, Ethyl, trifluoromethyl, isopropyl, tert-butyl; methylsulfonyl, methylsulfoxide, nitro, cyano, carbamoyl, N-methylcarbamoyl, N-ethylcarbamoyl , N, N-dimethylcarbamoyl, N, N-diethylcarbamoyl, methoxyl, ethoxyl, amino, acetamido, hydroxyl, methoxy, ethoxy. 7、按权利要求1、2或3所述的一种新型烷基取代的三氮唑类抗真菌化合物I中:Z代表7. In a novel alkyl-substituted triazole antifungal compound I according to claim 1, 2 or 3: Z represents X1-CX 1 -C X1为各种杂环,包括呋喃、噻吩、吡唑、咪唑、三氮唑、四氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶、嘧啶、哌嗪、吗啉、哌啶、吡唑酮、氢化吡唑酮、2-咪唑啉酮、4,5-二氢咪唑啉酮、1,2,4-三唑-3-酮; X1 is various heterocycles, including furan, thiophene, pyrazole, imidazole, triazole, tetrazole, oxazole, thiazole, isoxazole, pyran, pyridine, pyrimidine, piperazine, morpholine, piperidine , pyrazolone, hydrogenated pyrazolone, 2-imidazolinone, 4,5-dihydroimidazolinone, 1,2,4-triazol-3-one; 1)C为C1时,C11) When C is C 1 , C 1 is a.取代苯基,这里苯环上的取代基可以是1-3个,可以相同也可以不同,包括F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基、叔丁基等;甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N-甲基氨甲酰基、N-乙基氨甲酰基、N,N-二甲基氨甲酰基、N,N-二乙基氨甲酰基、甲氧酰基、乙氧酰基、氨基、乙酰氨基、羟基、甲氧基、乙氧基;取代基可位于苯环的各个位置;a. Substituted phenyl, where the substituents on the benzene ring can be 1-3, which can be the same or different, including F, Cl, Br, I; methyl, ethyl, trifluoromethyl, isopropyl, tert-butyl, etc.; methylsulfone, methylsulfoxide, nitro, cyano, carbamoyl, N-methylcarbamoyl, N-ethylcarbamoyl, N,N-dimethylcarbamoyl , N, N-diethylcarbamoyl, methoxyacyl, ethoxyacyl, amino, acetamido, hydroxyl, methoxy, ethoxy; substituents can be located at various positions of the benzene ring; b.取代杂环,这里的杂环是指五员或六员杂环,选自呋喃、噻吩、吡唑、咪唑、三氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶、嘧啶、吗啉和哌啶,杂环上取代基可位于杂环的各个位置,可以是单取代,也可以是多取代,包括F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基、叔丁基;甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N-甲基氨甲酰基、N-乙基氨甲酰基、N,N-二甲基氨甲酰基、N,N-二乙基氨甲酰基、甲氧酰基、乙氧酰基、氨基、乙酰氨基、羟基、甲氧基、乙氧基;b. Substituted heterocycle, here heterocycle refers to five-membered or six-membered heterocycle, selected from furan, thiophene, pyrazole, imidazole, triazole, oxazole, thiazole, isoxazole, pyran, pyridine, pyrimidine , morpholine and piperidine, the substituents on the heterocycle can be located at various positions of the heterocycle, and can be single-substituted or multi-substituted, including F, Cl, Br, I; methyl, ethyl, trifluoromethyl , isopropyl, tert-butyl; methylsulfonyl, methylsulfoxide, nitro, cyano, carbamoyl, N-methylcarbamoyl, N-ethylcarbamoyl, N,N-dimethyl Carbamoyl, N, N-diethylcarbamoyl, methoxyl, ethoxyl, amino, acetamido, hydroxyl, methoxy, ethoxy; c.取代芳香环甲基,这里的芳香环指常见的五员或六员芳香(杂)环,选自苯环、呋喃、噻吩、吡唑、咪唑、三氮唑、四氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶和嘧啶,芳香(杂)环上取代基可位于各个位置,可以是单取代,也可以是多取代,包括F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基、叔丁基;甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N-甲基氨甲酰基、N-乙基氨甲酰基、N,N-二甲基氨甲酰基、N,N-二乙基氨甲酰基、甲氧酰基、乙氧酰基、氨基、乙酰氨基、羟基、甲氧基、乙氧基;c. Substituted aromatic ring methyl, where the aromatic ring refers to a common five-membered or six-membered aromatic (hetero) ring, selected from benzene ring, furan, thiophene, pyrazole, imidazole, triazole, tetrazole, oxazole , thiazole, isoxazole, pyran, pyridine and pyrimidine, the substituents on the aromatic (hetero) ring can be located at various positions, and can be single or multiple substitutions, including F, Cl, Br, I; methyl, Ethyl, trifluoromethyl, isopropyl, tert-butyl; methylsulfonyl, methylsulfoxide, nitro, cyano, carbamoyl, N-methylcarbamoyl, N-ethylcarbamoyl , N, N-dimethylcarbamoyl, N, N-diethylcarbamoyl, methoxyl, ethoxyl, amino, acetamido, hydroxyl, methoxy, ethoxy; d.取代乙酰基,这里的取代基又指取代苯环和杂环,这里的杂环是指五员或六员杂环,选自呋喃、噻吩、吡唑、咪唑、三氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶、嘧啶、吗啉和哌啶,苯环和杂环上取代基为1-3个,可以是单取代,也可以是多取代,如F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基、叔丁基等;甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N-甲基氨甲酰基、N,N-二甲基氨甲酰基、甲氧酰基、乙氧酰基、氨基、乙酰氨基、羟基、甲氧基、乙氧基等;d. Substituted acetyl group, where the substituents refer to substituted benzene rings and heterocyclic rings, where the heterocyclic rings refer to five-membered or six-membered heterocyclic rings, selected from furan, thiophene, pyrazole, imidazole, triazole, oxazole , thiazole, isoxazole, pyran, pyridine, pyrimidine, morpholine and piperidine, the substituents on the benzene ring and the heterocycle are 1-3, which can be mono-substituted or multi-substituted, such as F, Cl, Br, I; methyl, ethyl, trifluoromethyl, isopropyl, tert-butyl, etc.; methylsulfonyl, methylsulfoxide, nitro, cyano, carbamoyl, N-methylcarbamoyl , N, N-dimethylcarbamoyl, methoxyl, ethoxyl, amino, acetamido, hydroxyl, methoxy, ethoxy, etc.; e.取代甲酰甲基,这里的取代基又指取代苯胺和杂环胺基,这里的杂环是指五员或六员杂环,选自呋喃、噻吩、吡唑、咪唑、三氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶、嘧啶、吗啉和哌啶,苯环和杂环上取代基为1-3个,可以是单取代,也可以是多取代,包括F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基、叔丁基;甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N,N-二甲基氨甲酰基、甲氧酰基、乙氧酰基、氨基、乙酰氨基、羟基、甲氧基、乙氧基;e. Substituted formylmethyl, where the substituent refers to substituted aniline and heterocyclic amine, where the heterocycle refers to a five-membered or six-membered heterocyclic ring, selected from furan, thiophene, pyrazole, imidazole, triazole , oxazole, thiazole, isoxazole, pyran, pyridine, pyrimidine, morpholine and piperidine, 1-3 substituents on the benzene ring and heterocycle, which can be mono-substituted or multi-substituted, including F , Cl, Br, I; methyl, ethyl, trifluoromethyl, isopropyl, tert-butyl; methylsulfonyl, methylsulfoxide, nitro, cyano, carbamoyl, N, N-di Methylcarbamoyl, methoxyl, ethoxyl, amino, acetamido, hydroxy, methoxy, ethoxy; 2)C为C2时,C22) When C is C 2 , C 2 is X2为S、O、NH; X2 is S, O, NH; E为:取代芳香环甲基,这里的芳香环指常见的五员或六员芳香(杂)环,选自苯环、呋喃、噻吩、吡唑、咪唑、三氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶和嘧啶,芳香(杂)环上取代基可位于各个位置,可以是单取代,也可以是多取代,包括F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基、叔丁基;甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N-甲基氨甲酰基、N-乙基氨甲酰基、N,N-二甲基氨甲酰基、N,N-二乙基氨甲酰基、甲氧酰基、乙氧酰基、氨基、乙酰氨基、羟基、甲氧基、乙氧基;E is: a substituted aromatic ring methyl group, where the aromatic ring refers to a common five-membered or six-membered aromatic (hetero) ring, selected from benzene ring, furan, thiophene, pyrazole, imidazole, triazole, oxazole, thiazole, Isoxazole, pyran, pyridine and pyrimidine, the substituents on the aromatic (hetero) ring can be located at various positions, and can be mono-substituted or multi-substituted, including F, Cl, Br, I; methyl, ethyl, Trifluoromethyl, isopropyl, tert-butyl; methylsulfonyl, methylsulfoxide, nitro, cyano, carbamoyl, N-methylcarbamoyl, N-ethylcarbamoyl, N, N-dimethylcarbamoyl, N,N-diethylcarbamoyl, methoxyl, ethoxyl, amino, acetamido, hydroxyl, methoxy, ethoxy; X2为NH时E还可以是取代芳香环甲酰基,这里的芳香环指常见五员或六员芳香(杂)环,选自苯环、呋喃、噻吩、吡唑、咪唑、三氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶和嘧啶,芳香(杂)环上取代基可位于各个位置,可以是单取代,也可以是多取代,包括F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基、叔丁基;甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N-甲基氨甲酰基、N-乙基氨甲酰基、N,N-二甲基氨甲酰基、甲氧酰基、乙氧酰基、乙酰氨基、羟基、甲氧基、乙氧基;When X2 is NH, E can also be a substituted aromatic ring formyl group, where the aromatic ring refers to a common five-membered or six-membered aromatic (hetero) ring, selected from benzene ring, furan, thiophene, pyrazole, imidazole, triazole, Oxazole, thiazole, isoxazole, pyran, pyridine and pyrimidine, the substituents on the aromatic (hetero) ring can be located at various positions, and can be single or multiple substitutions, including F, Cl, Br, I; Base, ethyl, trifluoromethyl, isopropyl, tert-butyl; methylsulfonyl, methylsulfoxide, nitro, cyano, carbamoyl, N-methylcarbamoyl, N-ethylamino Formyl, N, N-dimethylcarbamoyl, methoxyl, ethoxyl, acetamido, hydroxyl, methoxy, ethoxy; 3)C为C3时,C33) When C is C 3 , C 3 is Q为CH或N;G为:Q is CH or N; G is: a.含有1-6个碳原子的基团,包括甲基、乙基、三氟甲基、异丙基、异丁基、环戊基和环己基;a. Groups containing 1-6 carbon atoms, including methyl, ethyl, trifluoromethyl, isopropyl, isobutyl, cyclopentyl and cyclohexyl; b.取代芳香环,这里的芳香环指常见的五员或六员芳香(杂)环,选自苯环、呋喃、噻吩、吡唑、咪唑、三氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶和嘧啶,芳香(杂)环上取代基可位于各个位置,可以是单取代,也可以是多取代,包括F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基和叔丁基;甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N-甲基氨甲酰基、N-乙基氨甲酰基、N,N-二甲基氨甲酰基、N,N-二乙基氨甲酰基、甲氧酰基、乙氧酰基、氨基、乙酰氨基、羟基、甲氧基、乙氧基;b. Substituted aromatic ring, where the aromatic ring refers to a common five-membered or six-membered aromatic (hetero) ring, selected from benzene ring, furan, thiophene, pyrazole, imidazole, triazole, oxazole, thiazole, isoxazole , pyran, pyridine and pyrimidine, the substituents on the aromatic (hetero) ring can be located at various positions, and can be single or multiple substitutions, including F, Cl, Br, I; methyl, ethyl, trifluoromethyl group, isopropyl and tert-butyl; methylsulfonyl, methylsulfoxide, nitro, cyano, carbamoyl, N-methylcarbamoyl, N-ethylcarbamoyl, N,N-di Methylcarbamoyl, N,N-diethylcarbamoyl, methoxyl, ethoxyl, amino, acetamido, hydroxyl, methoxy, ethoxy; c.取代芳香环甲基,这里的芳香环指常见的五员或六员芳香(杂)环,选自苯环、呋喃、噻吩、吡唑、咪唑、三氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶和嘧啶,芳香(杂)环上取代基可位于各个位置,可以是单取代,也可以是多取代,包括F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基、叔丁基;甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N,N-二甲基氨甲酰基、N,N-二乙基氨甲酰基、甲氧酰基、乙氧酰基、氨基、乙酰氨基、羟基、甲氧基、乙氧基;c. Substituted aromatic ring methyl, where the aromatic ring refers to a common five-membered or six-membered aromatic (hetero) ring, selected from benzene ring, furan, thiophene, pyrazole, imidazole, triazole, oxazole, thiazole, iso Oxazole, pyran, pyridine and pyrimidine, the substituents on the aromatic (hetero) ring can be located at various positions, and can be mono-substituted or multi-substituted, including F, Cl, Br, I; methyl, ethyl, tri Fluoromethyl, isopropyl, tert-butyl; methylsulfonyl, methylsulfoxide, nitro, cyano, carbamoyl, N,N-dimethylcarbamoyl, N,N-diethylammonia Formyl, methoxyl, ethoxyl, amino, acetamido, hydroxy, methoxy, ethoxy; 4)C为C4时,C44) When C is C 4 , C 4 is
Figure A2005100307460006C2
Figure A2005100307460006C3
Figure A2005100307460006C2
and
Figure A2005100307460006C3
R2为:1-3个F、Cl、Br,可以相同也可以不同,A和A1可以为O、S、N或NH,R3为:R 2 is: 1-3 F, Cl, Br, can be the same or different, A and A 1 can be O, S, N or NH, R 3 is: 1)含有1-6个碳原子的基团,包括甲基、乙基、丙基、环丙基、环丁基、环戊基和环己基;1) groups containing 1-6 carbon atoms, including methyl, ethyl, propyl, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl; 2)取代芳香环,这里的芳香环指常见的五员或六员芳香(杂)环,选自苯环、呋喃、噻吩、吡唑、咪唑、三氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶和嘧啶,芳香(杂)环上取代基可位于各个位置,可以是单取代,也可以是多取代,包括F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基、叔丁基;甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N,N-二甲基氨甲酰基、N,N-二乙基氨甲酰基、甲氧酰基、乙氧酰基、氨基、乙酰氨基、羟基、甲氧基、乙氧基;2) A substituted aromatic ring, where the aromatic ring refers to a common five-membered or six-membered aromatic (hetero) ring, selected from benzene ring, furan, thiophene, pyrazole, imidazole, triazole, oxazole, thiazole, isoxazole , pyran, pyridine and pyrimidine, the substituents on the aromatic (hetero) ring can be located at various positions, and can be single or multiple substitutions, including F, Cl, Br, I; methyl, ethyl, trifluoromethyl Base, isopropyl, tert-butyl; methylsulfonyl, methylsulfoxide, nitro, cyano, carbamoyl, N,N-dimethylcarbamoyl, N,N-diethylcarbamoyl , methoxyl, ethoxyl, amino, acetamido, hydroxyl, methoxy, ethoxy; 3)取代芳香环甲基,这里的芳香环指常见的五员或六员芳香(杂)环,选自苯环、呋喃、噻吩、吡唑、咪唑、三氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶和嘧啶,芳香(杂)环上取代基可位于各个位置,可以是单取代,也可以是多取代,包括F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基、叔丁基;甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N,N-二甲基氨甲酰基、N,N-二乙基氨甲酰基、甲氧酰基、乙氧酰基、氨基、乙酰氨基、羟基、甲氧基、乙氧基。3) A substituted aromatic ring methyl group, where the aromatic ring refers to a common five-membered or six-membered aromatic (hetero) ring, selected from benzene ring, furan, thiophene, pyrazole, imidazole, triazole, oxazole, thiazole, iso Oxazole, pyran, pyridine and pyrimidine, the substituents on the aromatic (hetero) ring can be located at various positions, and can be mono-substituted or multi-substituted, including F, Cl, Br, I; methyl, ethyl, tri Fluoromethyl, isopropyl, tert-butyl; methylsulfonyl, methylsulfoxide, nitro, cyano, carbamoyl, N,N-dimethylcarbamoyl, N,N-diethylammonia Formyl, methoxyl, ethoxyl, amino, acetamido, hydroxy, methoxy, ethoxy.
8、按权利要求1、2或3所述的一种新型烷基取代的三氮唑类抗真菌化合物I中:8. In a novel alkyl-substituted triazole antifungal compound I according to claim 1, 2 or 3: Z代表:Z stands for: R1为: R1 is: 1)含有1-6个碳原子的基团,包括甲基、乙基、乙酰基、异丙基、丙酰基和丁酰基;1) groups containing 1-6 carbon atoms, including methyl, ethyl, acetyl, isopropyl, propionyl and butyryl; 2)取代芳香环,这里的芳香环指常见的五员或六员芳香(杂)环,选自苯环、呋喃、噻吩、吡唑、咪唑、三氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶和嘧啶,芳香(杂)环上取代基可位于各个位置,可以是单取代,也可以是多取代,包括F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基、叔丁基;甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N-甲基氨甲酰基、N-乙基氨甲酰基、N,N-二甲基氨甲酰基、N,N-二乙基氨甲酰基、甲氧酰基、乙氧酰基、氨基、乙酰氨基、羟基、甲氧基、乙氧基;2) A substituted aromatic ring, where the aromatic ring refers to a common five-membered or six-membered aromatic (hetero) ring, selected from benzene ring, furan, thiophene, pyrazole, imidazole, triazole, oxazole, thiazole, isoxazole , pyran, pyridine and pyrimidine, the substituents on the aromatic (hetero) ring can be located at various positions, and can be single or multiple substitutions, including F, Cl, Br, I; methyl, ethyl, trifluoromethyl Base, isopropyl, tert-butyl; methylsulfonyl, methylsulfoxide, nitro, cyano, carbamoyl, N-methylcarbamoyl, N-ethylcarbamoyl, N,N-two Methylcarbamoyl, N,N-diethylcarbamoyl, methoxyl, ethoxyl, amino, acetamido, hydroxyl, methoxy, ethoxy; 3)取代芳香环甲基,这里的芳香环指常见的五员或六员芳香(杂)环,选自苯环、呋喃、噻吩、吡唑、咪唑、三氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶和嘧啶,芳香(杂)环上取代基可位于各个位置,可以是单取代,也可以是多取代,包括F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基、叔丁基;甲砜基、甲亚砜基、硝基、氰基、氨甲酰基、N-甲基氨甲酰基、N-乙基氨甲酰基、N,N-二甲基氨甲酰基、N,N-二乙基氨甲酰基、甲氧酰基、乙氧酰基、氨基、甲酰氨基、乙酰氨基、羟基、甲氧基、乙氧基;3) A substituted aromatic ring methyl group, where the aromatic ring refers to a common five-membered or six-membered aromatic (hetero) ring, selected from benzene ring, furan, thiophene, pyrazole, imidazole, triazole, oxazole, thiazole, iso Oxazole, pyran, pyridine and pyrimidine, the substituents on the aromatic (hetero) ring can be located at various positions, and can be mono-substituted or multi-substituted, including F, Cl, Br, I; methyl, ethyl, tri Fluoromethyl, isopropyl, tert-butyl; methylsulfonyl, methylsulfoxide, nitro, cyano, carbamoyl, N-methylcarbamoyl, N-ethylcarbamoyl, N, N -Dimethylcarbamoyl, N,N-diethylcarbamoyl, methoxyacyl, ethoxyacyl, amino, formamido, acetamido, hydroxyl, methoxy, ethoxy; 4)取代芳香环甲酰基,这里的芳香环指常见的五员或六员芳香(杂)环,选自苯环、呋喃、噻吩、吡唑、咪唑、三氮唑、噁唑、噻唑、异噁唑、吡喃、吡啶和嘧啶,芳香(杂)环上取代基可位于各个位置,可以是单取代,也可以是多取代,包括F、Cl、Br、I;甲基、乙基、三氟甲基、异丙基、叔丁基;甲砜基、甲亚砜基、硝基、氰基、乙酰氨基、羟基、甲氧基、乙氧基;4) Substituted aromatic ring formyl, where the aromatic ring refers to a common five-membered or six-membered aromatic (hetero) ring, selected from benzene ring, furan, thiophene, pyrazole, imidazole, triazole, oxazole, thiazole, iso Oxazole, pyran, pyridine and pyrimidine, the substituents on the aromatic (hetero) ring can be located at various positions, and can be single or multiple substitutions, including F, Cl, Br, I; methyl, ethyl, tri Fluoromethyl, isopropyl, tert-butyl; methylsulfonyl, methylsulfoxide, nitro, cyano, acetamido, hydroxyl, methoxy, ethoxy; 5)5) Q为CH或N;Y为包括甲基、乙基、三氟甲基、异丙基、异丁基和异戊基在内的1-6个碳原子的基团。Q is CH or N; Y is a group of 1-6 carbon atoms including methyl, ethyl, trifluoromethyl, isopropyl, isobutyl and isopentyl.
CN 200510030746 2005-10-27 2005-10-27 Antifungal compound of alkyl substitutional triazole class Pending CN1760193A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510030746 CN1760193A (en) 2005-10-27 2005-10-27 Antifungal compound of alkyl substitutional triazole class

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510030746 CN1760193A (en) 2005-10-27 2005-10-27 Antifungal compound of alkyl substitutional triazole class

Publications (1)

Publication Number Publication Date
CN1760193A true CN1760193A (en) 2006-04-19

Family

ID=36706438

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510030746 Pending CN1760193A (en) 2005-10-27 2005-10-27 Antifungal compound of alkyl substitutional triazole class

Country Status (1)

Country Link
CN (1) CN1760193A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101781263A (en) * 2010-03-04 2010-07-21 中国人民解放军第二军医大学 Nitrogen methyl side chain-substituted triadimenol antifungal compound and preparation method thereof
CN102796087A (en) * 2012-09-04 2012-11-28 西南大学 Coumarin triadimenol, and preparation method and application thereof
CN103450162A (en) * 2013-08-08 2013-12-18 中国人民解放军第一○二医院 Triazole alcohol compound containing benzamide structure and preparation method and application of triazole alcohol compound
WO2014167010A1 (en) * 2013-04-12 2014-10-16 Bayer Cropscience Ag Novel triazole derivatives
WO2014167009A1 (en) 2013-04-12 2014-10-16 Bayer Cropscience Ag Novel triazole derivatives
WO2014167008A1 (en) 2013-04-12 2014-10-16 Bayer Cropscience Ag Novel triazolinthione derivatives
WO2016050769A1 (en) 2014-10-02 2016-04-07 Bayer Cropscience Aktiengesellschaft Novel triazole derivatives useful as fungicides
WO2016156294A1 (en) 2015-04-02 2016-10-06 Bayer Cropscience Aktiengesellschaft Triazol derivatives as fungicides

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101781263B (en) * 2010-03-04 2012-05-30 中国人民解放军第二军医大学 Nitrogen methyl side chain-substituted triadimenol antifungal compound and preparation method thereof
CN101781263A (en) * 2010-03-04 2010-07-21 中国人民解放军第二军医大学 Nitrogen methyl side chain-substituted triadimenol antifungal compound and preparation method thereof
CN102796087B (en) * 2012-09-04 2015-04-15 西南大学 Coumarin triadimenol, and preparation method and application thereof
CN102796087A (en) * 2012-09-04 2012-11-28 西南大学 Coumarin triadimenol, and preparation method and application thereof
JP2016518353A (en) * 2013-04-12 2016-06-23 バイエル・クロップサイエンス・アクチェンゲゼルシャフト New triazole derivatives
US9550752B2 (en) 2013-04-12 2017-01-24 Bayer Cropscience Aktiengesellschaft Triazolinthione derivatives
WO2014167008A1 (en) 2013-04-12 2014-10-16 Bayer Cropscience Ag Novel triazolinthione derivatives
WO2014167010A1 (en) * 2013-04-12 2014-10-16 Bayer Cropscience Ag Novel triazole derivatives
CN105283450A (en) * 2013-04-12 2016-01-27 拜耳作物科学股份公司 Novel triazole derivatives
CN105283449A (en) * 2013-04-12 2016-01-27 拜耳作物科学股份公司 Novel triazolinthione derivatives
CN105308032A (en) * 2013-04-12 2016-02-03 拜耳作物科学股份公司 Novel triazole derivatives
CN105283450B (en) * 2013-04-12 2018-12-18 拜耳作物科学股份公司 Triazole derivative
TWI633097B (en) * 2013-04-12 2018-08-21 拜耳作物科學股份有限公司 Novel triazole derivatives
JP2016520555A (en) * 2013-04-12 2016-07-14 バイエル・クロップサイエンス・アクチェンゲゼルシャフト New triazole derivatives
EA030024B1 (en) * 2013-04-12 2018-06-29 Байер Кропсайенс Акциенгезельшафт Novel triazole derivatives for controlling phytopathogenic harmful fungi
WO2014167009A1 (en) 2013-04-12 2014-10-16 Bayer Cropscience Ag Novel triazole derivatives
CN105308032B (en) * 2013-04-12 2017-05-24 拜耳作物科学股份公司 Novel triazole derivatives
US9668481B2 (en) 2013-04-12 2017-06-06 Bayer Cropscience Aktiengesellschaft Triazole derivatives
US9822099B2 (en) 2013-04-12 2017-11-21 Bayer Cropscience Aktiengesellschaft Triazole derivatives
TWI609632B (en) * 2013-04-12 2018-01-01 拜耳作物科學股份有限公司 Novel triazolinthione derivatives
EA028812B1 (en) * 2013-04-12 2018-01-31 Байер Кропсайенс Акциенгезельшафт Triazole derivatives
TWI621617B (en) * 2013-04-12 2018-04-21 德商拜耳作物科學股份有限公司 Novel triazole derivatives
CN103450162A (en) * 2013-08-08 2013-12-18 中国人民解放军第一○二医院 Triazole alcohol compound containing benzamide structure and preparation method and application of triazole alcohol compound
WO2016050769A1 (en) 2014-10-02 2016-04-07 Bayer Cropscience Aktiengesellschaft Novel triazole derivatives useful as fungicides
WO2016156294A1 (en) 2015-04-02 2016-10-06 Bayer Cropscience Aktiengesellschaft Triazol derivatives as fungicides

Similar Documents

Publication Publication Date Title
CN1026788C (en) The preparation method of triazole antifungal agent
CN1310907C (en) Heterocyclic compound and antitumour agent containing the same as active ingredient
CN1094937C (en) Farnesyltransferase inhibiting quinazolinones
CN1036920C (en) Heterocyclic carbonic acid derivatives
CN1028226C (en) 4-Oxoquinoline-3-carboxylic acid derivatives, their preparation and their use
CN1221417A (en) Thiazolidinedione compound with antidiabetic, blood lipid lowering and antihypertensive properties, preparation method and pharmaceutical composition thereof
CN1053190C (en) Quinoxalindione derivs., their preparation and their use in drugs
CN1471523A (en) Imidazole Raffinokinase Inhibitors
CN1068329A (en) pyrazolopyrimidinone antianginal agent
CN1114959A (en) Novel quinoline carboxylic acid derivatives having 7-(4-aminomethyl-3-oxime) pyrrolidine substituent and processes for preparing thereof
CN1051359A (en) Improved imidazo [4, the 5-b] quinolinyloxyalkanoic acid amides of water-soluble degree
CN1202107A (en) Selective 'beta'3 adrenergic agonists
CN1044811A (en) Heterocyclic compound
CN1639159A (en) N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as DDP-IV inhibitors
CN1845921A (en) Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as DPP-IV inhibitors
CN1155599C (en) Tricyclic triazolobenzazepine * derivatives, process for preparing the same, and antiallergic agent
CN1251098A (en) Pyrrole compounds, their prodn. and their use
CN1349524A (en) Renin inhibitors
CN1157376C (en) Arylpiperidinopropanol and arylpiperazinopropanol derivatives and drugs containing the same
CN1106390A (en) Pyrrole compound, its production and application
CN1069640C (en) Adhesion receptor antagonists
CN1760193A (en) Antifungal compound of alkyl substitutional triazole class
CN1217722A (en) Process for preparing pyrimidine derivatives
CN1671717A (en) Azole derivatives as antifungal agents
CN1079745A (en) New 9-fluoro-7-oxo-7H-pyrido [1,2,3-d, e] [1,4] benzoxazine-6-carboxylic acids and ester thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication